| For: | Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008; 14(27): 4300-4308 [PMID: 18666317 DOI: 10.3748/wjg.14.4300] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i27/4300.htm |
| Number | Citing Articles |
| 1 |
Seulki Lee, Minjong Lee, Jong Bin Kim, Ara Jo, Eun Ju Cho, Su Jong Yu, Jeong-Hoon Lee, Jung-Hwan Yoon, Yoon Jun Kim. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling. Biochemical and Biophysical Research Communications 2016; 473(4) doi: 10.1016/j.bbrc.2016.04.049
|
| 2 |
Mirko Tarocchi, Simone Polvani, Giada Marroncini, Andrea Galli. Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World Journal of Gastroenterology 2014; 20(33): 11630-11640 doi: 10.3748/wjg.v20.i33.11630
|
| 3 |
Sergei N Shchelkunov, Galina A Shchelkunova. Plant-based vaccines against human hepatitis B virus. Expert Review of Vaccines 2010; 9(8) doi: 10.1586/erv.10.67
|
| 4 |
Xin Xu, Yuquan Tao, Yongjie Niu, Zhixian Wang, Congcong Zhang, Yongchun Yu, Lifang Ma. miR-125a-5p inhibits tumorigenesis in hepatocellular carcinoma. Aging 2019; 11(18) doi: 10.18632/aging.102276
|
| 5 |
EMILIA HADZIYANNIS, KONSTANTINOS SIALEVRIS, ANASTASIA GEORGIOU, JOHN KOSKINAS. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels. Oncology Reports 2013; 29(2) doi: 10.3892/or.2012.2147
|
| 6 |
C. Rory Goodwin, Vijay Yanamadala, Alejandro Ruiz-Valls, Nancy Abu-Bonsrah, Ganesh Shankar, Eric W. Sankey, Christine Boone, Michelle J. Clarke, Mark Bilsky, Ilya Laufer, Charles Fisher, John H. Shin, Daniel M. Sciubba. A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine. World Neurosurgery 2016; 91 doi: 10.1016/j.wneu.2016.04.026
|
| 7 |
Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. World Journal of Gastroenterology 2022; 28(21): 2251-2281 doi: 10.3748/wjg.v28.i21.2251
|
| 8 |
Rebecca Jeyaraj, Deirdre Kelly. Rare Inherited Cholestatic Disorders and Molecular Links to Hepatocarcinogenesis. Cells 2022; 11(16) doi: 10.3390/cells11162570
|
| 9 |
Francesco Paolo Russo, Kryssia Rodríguez-Castro, Laura Scribano, Giorgia Gottardo, Veronica Vanin, Fabio Farinati. Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease. World Journal of Hepatology 2015; 7(8): 1097-1104 doi: 10.4254/wjh.v7.i8.1097
|
| 10 |
Sk Ramiz Islam, Soumen Kanti Manna. Identification of glucose-independent and reversible metabolic pathways associated with anti-proliferative effect of metformin in liver cancer cells. Metabolomics 2024; 20(2) doi: 10.1007/s11306-024-02096-0
|
| 11 |
|
| 12 |
Joji Nakayama, Zhiyuan Gong. Transgenic zebrafish for modeling hepatocellular carcinoma. MedComm 2020; 1(2) doi: 10.1002/mco2.29
|
| 13 |
Shuang Liu, Jie An, Jianhong Lin, Yanli Liu, Lidao Bao, Wen Zhang, Jian-Jun Zhao, Zhengdong Zhang. Single Nucleotide Polymorphisms of MicroRNA Processing Machinery Genes and Outcome of Hepatocellular Carcinoma. PLoS ONE 2014; 9(3) doi: 10.1371/journal.pone.0092791
|
| 14 |
|
| 15 |
Ali Habib, Kush Desai, Ryan Hickey, Bartley Thornburg, Robert Lewandowski, Riad Salem. Transarterial approaches to primary and secondary hepatic malignancies. Nature Reviews Clinical Oncology 2015; 12(8) doi: 10.1038/nrclinonc.2015.78
|
| 16 |
Peng Yuan, Peng Chen, Yeben Qian. Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology 2016; 2016 doi: 10.1155/2016/5234969
|
| 17 |
Kheng Leong Ooi, Tengku Sifzizul Tengku Muhammad, Lee Yein Lam, Shaida Fariza Sulaiman. Cytotoxic and Apoptotic Effects of Ethyl Acetate Extract of Elephantopus mollis Kunth. in Human Liver Carcinoma HepG2 Cells Through Caspase-3 Activation. Integrative Cancer Therapies 2014; 13(3) doi: 10.1177/1534735411433203
|
| 18 |
Ola M Eid, Nivine A Helmy, Islam H Fadel, Waffa M Ezzat, Refaat R Kamel, Maha M Eid. Hepatitis C virus and schistosomiasis as a causative factor for hTERT amplification in hepatocellular carcinoma. Gene Reports 2016; 5 doi: 10.1016/j.genrep.2016.09.013
|
| 19 |
Kyle J. Thompson, Kwan N. Lau, Sarah Johnson, John B. Martinie, David A. Iannitti, Iain H. McKillop, David Sindram. Leptin inhibits hepatocellular carcinoma proliferation via p38-MAPK-dependent signalling. HPB 2011; 13(4) doi: 10.1111/j.1477-2574.2010.00259.x
|
| 20 |
Debojyoti Halder, Ashutosh Gupta, Subhasis Chakraborty, Partha Roy, Kalyan Kumar Sen. Upgraded theragnostic strategies of multivariate nano gold in the management of hepatocellular carcinoma. Nano-Structures & Nano-Objects 2024; 40 doi: 10.1016/j.nanoso.2024.101342
|
| 21 |
Xiaotong Su, Jutong Su, Hua He, Yong Zhan, Haichao Liu. Hsa_circ_0070269 inhibits hepatocellular carcinoma progression through modulating miR-182/NPTX1 axis. Biomedicine & Pharmacotherapy 2019; 120 doi: 10.1016/j.biopha.2019.109497
|
| 22 |
Duguang Li, Junhai Pan, Yiyin Zhang, Yirun Li, Shengxi Jin, Cheng Zhong, Peng Chen, Jingjing Ma, Wendi Hu, Xiaoxiao Fan, Hui Lin. C8orf76 Modulates Ferroptosis in Liver Cancer via Transcriptionally Up-Regulating SLC7A11. Cancers 2022; 14(14) doi: 10.3390/cancers14143410
|
| 23 |
Qing-Lian Chen, Qian Yan, Kun-Liang Feng, Chun-Feng Xie, Chong-Kai Fang, Ji-Nan Wang, Li-Hua Liu, Ya Li, Chong Zhong. Using Integrated Bioinformatics Analysis to Identify Abnormally Methylated Differentially Expressed Genes in Hepatocellular Carcinoma. International Journal of General Medicine 2021; doi: 10.2147/IJGM.S294505
|
| 24 |
Thu Ngoc Anh Nguyen, Piyanoot Thongsri, Yongyut Pewkliang, Mullika Traidej Chomnawang, Krit Thirapanmethee, Khanit Sa-ngiamsuntorn. Natural products targeting hepatitis B virus X protein and HBx-associated pathways in HBV-related hepatocellular carcinoma: mechanisms and therapeutic potential. Pharmaceutical Biology 2026; 64(1) doi: 10.1080/13880209.2026.2724161
|
| 25 |
Xiang Lyu, Kui Liu, Yongdi Chen, Zhifang Wang, Jun Yao, Gaofeng Cai, Zhenggang Jiang, Zhengting Wang, Jianmin Jiang, Hua Gu. Analysis of Risk Factors Associated with the Development of Hepatocellular Carcinoma in Chronic HBV-Infected Chinese: A Meta-Analysis. International Journal of Environmental Research and Public Health 2016; 13(6) doi: 10.3390/ijerph13060604
|
| 26 |
. 2017; doi: 10.70675/6fcac6ecz49b8z4ebaz878azeb4d4234be1b
|
| 27 |
A V Tkachev, G N Tarasova, V S Groshilin, D A Vasilchenkov, T I Ushakova, D V Blinov. Prevalence of nonalcoholic fatty liver disease in outpatients in Rostov-on-Don: Regional results of the DIREG-2 study. Terapevticheskii arkhiv 2016; 88(8) doi: 10.17116/terarkh201688859-66
|
| 28 |
K. Tajima, A. Nakamura, J. Shirakawa, Y. Togashi, K. Orime, K. Sato, H. Inoue, M. Kaji, E. Sakamoto, Y. Ito, K. Aoki, Y. Nagashima, T. Atsumi, Y. Terauchi. Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice. American Journal of Physiology-Endocrinology and Metabolism 2013; 305(8) doi: 10.1152/ajpendo.00133.2013
|
| 29 |
Yang Liu, Kazuyuki Sogawa, Masahiko Sunaga, Hiroshi Umemura, Mamoru Satoh, Takahiro Kazami, Masaharu Yoshikawa, Takeshi Tomonaga, Osamu Yokosuka, Fumio Nomura. Increased Concentrations of Apo A-I and Apo A-II Fragments in the Serum of Patients With Hepatocellular Carcinoma by Magnetic Beads–Assisted MALDI-TOF Mass Spectrometry. American Journal of Clinical Pathology 2014; 141(1) doi: 10.1309/AJCPBLFBNAP6N2UN
|
| 30 |
Sarah Hassan, Soheir S Mansy, Sahar A Tabak, Ahmed S AbdelFattah, Ahmed M Abdel-Aziz, Olfat Hamam, Mohammed I Seleem, Amr Abdelaal. Immunohistochemical and electron microscopic morphometric image analysis of hepatocellular carcinoma in association of HCV infection. Ultrastructural Pathology 2018; 42(2) doi: 10.1080/01913123.2017.1422065
|
| 31 |
Francisco Tustumi, Fabricio Ferreira Coelho, Daniel de Paiva Magalhães, Sérgio Silveira Júnior, Vagner Birk Jeismann, Gilton Marques Fonseca, Jaime Arthur Pirola Kruger, Luiz Augusto Carneiro D'Albuquerque, Paulo Herman. Treatment of hepatocellular carcinoma with macroscopic vascular invasion: A systematic review and network meta-analysis. Transplantation Reviews 2023; 37(3) doi: 10.1016/j.trre.2023.100763
|
| 32 |
K. Sartorius, B. Sartorius, C. Aldous, P.S. Govender, T.E. Madiba. Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications. Cancer Epidemiology 2015; 39(3) doi: 10.1016/j.canep.2015.04.006
|
| 33 |
Wasim Jafri, Muhammad Kamran. Hepatocellular Carcinoma in Asia: A Challenging Situation. Euroasian Journal of Hepato-Gastroenterology 2019; 9(1) doi: 10.5005/jp-journals-10018-1292
|
| 34 |
E H Yun, M K Lim, J-K Oh, J H Park, A Shin, J Sung, E-C Park. Combined effect of socioeconomic status, viral hepatitis, and lifestyles on hepatocelluar carcinoma risk in Korea. British Journal of Cancer 2010; 103(5) doi: 10.1038/sj.bjc.6605803
|
| 35 |
Javier Ampuero, Manuel Romero-Gomez. Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin. World Journal of Hepatology 2015; 7(8): 1105-1111 doi: 10.4254/wjh.v7.i8.1105
|
| 36 |
Mohamed A. Elwakil, Ekbal M. Abo-Hashem, Yasser M. Shabana, Mohamed A. El-Metwall, Ghada El-Kannish, Ali M. El-Adl, Rokiah Anwar, Eman Fawzy, Narmin Saied, Mustafa M. El-Zayat. Hepatocellular Carcinoma in Populations Consuming Heavy
Metals Contaminated Plants in North Delta, Egypt. Research Journal of Environmental Toxicology 2017; 11(2) doi: 10.3923/rjet.2017.55.61
|
| 37 |
Yoshitaka Takuma, Kazuhiro Nouso, Yasuhiro Makino, Tomoyuki Gotoh, Nobuyuki Toshikuni, Youichi Morimoto, Hiroyuki Shimomura, Hiroshi Yamamoto. Outcomes after curative treatment for cryptogenic cirrhosis‐associated hepatocellular carcinoma satisfying the Milan criteria. Journal of Gastroenterology and Hepatology 2011; 26(9) doi: 10.1111/j.1440-1746.2011.06775.x
|
| 38 |
Ana Paula Pagano, Juliana Maria Faccioli Sicchieri, Clara Romanholi Passos, Camila Sanches Manca, Isabela Laurencio Schiavoni, Andreza Correa Teixeira, Ana de Lourdes Candolo Martinelli, Paula Garcia Chiarello. Hand grip strength and adductor pollicis muscle thickness in patients on palliative care for hepatocellular carcinoma. Clinical Nutrition Experimental 2018; 22 doi: 10.1016/j.yclnex.2018.06.003
|
| 39 |
Yoshitaka Takuma, Hiroyuki Takabatake, Youichi Morimoto, Nobuyuki Toshikuni, Takahisa Kayahara, Yasuhiro Makino, Hiroshi Yamamoto. Comparison of Combined Transcatheter Arterial Chemoembolization and Radiofrequency Ablation with Surgical Resection by Using Propensity Score Matching in Patients with Hepatocellular Carcinoma within Milan Criteria. Radiology 2013; 269(3) doi: 10.1148/radiol.13130387
|
| 40 |
Neneng Ratnasari, Puji Lestari, Dede Renovaldi, Juwita Raditya Ningsih, Nanda Qoriansas, Tirta Wardana, Suharno Hakim, Nur Signa Aini Gumilas, Fahmi Indrarti, Catharina Triwikatmani, Putut Bayupurnama, Didik Setyo Heriyanto, Indwiani Astuti, Sofia Mubarika Harjana, Ratna B. Ray. Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients. PLOS ONE 2022; 17(2) doi: 10.1371/journal.pone.0263298
|
| 41 |
Yun Hak Kim, Dae Cheon Jeong, Kyoungjune Pak, Myoung-Eun Han, Ji-Young Kim, Liu Liangwen, Hyun Jin Kim, Tae Woo Kim, Tae Hwa Kim, Dong Woo Hyun, Sae-Ock Oh. SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma. Oncotarget 2017; 8(40) doi: 10.18632/oncotarget.20266
|
| 42 |
Ibrahim Büdeyri, Olaf Guckelberger, Elsie Oppermann, Dhruvajyoti Roy, Svenja Sliwinski, Felix Becker, Benjamin Struecker, Thomas J. Vogl, Andreas Pascher, Wolf O. Bechstein, Anna Lorentzen, Mathias Heikenwalder, Mazen A. Juratli. Ezrin Polarization as a Diagnostic Marker for Circulating Tumor Cells in Hepatocellular Carcinoma. Cells 2024; 14(1) doi: 10.3390/cells14010006
|
| 43 |
Bipul Gnyawali, Antoinette Pusateri, Ashley Nickerson, Sajid Jalil, Khalid Mumtaz. Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma. World Journal of Gastroenterology 2022; 28(29): 3793-3802 doi: 10.3748/wjg.v28.i29.3793
|
| 44 |
Kennedy Yao Yi Ng, Lawrence Wen Jun Wong, Andrea Jing Shi Ang, Ailica Wan Xin Lee, Desiree Shu Hui Tay, Jack Jie En Tan, Sze Huey Tan, Su Pin Choo, David Wai‐Meng Tai, Joycelyn Jie Xin Lee. Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?. Asia-Pacific Journal of Clinical Oncology 2023; 19(3) doi: 10.1111/ajco.13837
|
| 45 |
Linyou Cheng, Ming Liu, Cuicui Wang, Haizhou Liu, Yuyan Zhang, Xiukun Lin. CI431, an Aqueous Compound from Ciona intestinalis L., Induces Apoptosis through a Mitochondria‐Mediated Pathway in Human Hepatocellular Carcinoma Cells. Evidence-Based Complementary and Alternative Medicine 2011; 2011(1) doi: 10.1155/2011/292873
|
| 46 |
Han-Syuan Lin, Yi-Luen Huang, Yi-Rui Stefanie Wang, Eugene Hsiao, Tsu-An Hsu, Hui-Yi Shiao, Weir-Torn Jiaang, Bonifasius Putera Sampurna, Kuan-Hao Lin, Ming-Shun Wu, Gi-Ming Lai, Chiou-Hwa Yuh. Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index Than Sorafenib via Zebrafish Drug Screening Platform. Cancers 2019; 11(6) doi: 10.3390/cancers11060739
|
| 47 |
Young-Joo Jin, Seyoun Byun, Seonggyun Han, John Chamberlin, Dongwook Kim, Min Jung Kim, Younghee Lee. Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors. BMC Medical Genomics 2019; 12(S8) doi: 10.1186/s12920-019-0635-z
|
| 48 |
Ruixing Zhang, Fengbin Zhang, Cuiju Wang, Shunxiang Wang, Yih-Horng Shiao, Zhanjun Guo. Identification of sequence polymorphism in the D-Loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology. Journal of Experimental & Clinical Cancer Research 2010; 29(1) doi: 10.1186/1756-9966-29-130
|
| 49 |
Luca Quagliata, Matthias S. Matter, Salvatore Piscuoglio, Leila Arabi, Christian Ruiz, Alfredo Procino, Michal Kovac, Francesca Moretti, Zuzanna Makowska, Tujana Boldanova, Jesper B. Andersen, Monika Hämmerle, Luigi Tornillo, Markus H. Heim, Sven Diederichs, Clemente Cillo, Luigi M. Terracciano. Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology 2014; 59(3) doi: 10.1002/hep.26740
|
| 50 |
Anokh Pahwa, Katrina Beckett, Stephanie Channual, Nelly Tan, David S. Lu, Steven S. Raman. Efficacy of the American Association for the Study of Liver Disease and Barcelona criteria for the diagnosis of hepatocellular carcinoma. Abdominal Imaging 2014; 39(4) doi: 10.1007/s00261-014-0118-9
|
| 51 |
Hitoshi Maruyama, Arun J. Sanyal. Clinical Dilemmas in Primary Liver Cancer. 2011; doi: 10.1002/9781119962205.ch5
|
| 52 |
Bita Geramizadeh, Nasibe Seirfar. Diagnostic Value of Arginase-1 and Glypican-3 in Differential Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Metastatic Carcinoma of Liver. Hepatitis Monthly 2015; 15(6) doi: 10.5812/hepatmon30336v2
|
| 53 |
|
| 54 |
G A Siregar, R H Siregar. Gamma-glutamyltranspeptidase to platelet ratio and albumin to gamma-glutamyltranspeptidase between degrees of the Barcelona clinic liver cancer on hepatocellular carcinoma patients in Haji Adam Malik general hospital Medan during 2015-2016. IOP Conference Series: Earth and Environmental Science 2018; 125 doi: 10.1088/1755-1315/125/1/012135
|
| 55 |
Ágnes Holczbauer, Kirk J. Wangensteen, Soona Shin. Cellular origins of regenerating liver and hepatocellular carcinoma. JHEP Reports 2022; 4(4) doi: 10.1016/j.jhepr.2021.100416
|
| 56 |
Won-Mook Choi, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, W. Ray Kim, Leland J. Yee, Craig Brooks-Rooney, Tristan Curteis, Harriet Cant, Chien-Hung Chen, Chi-Yi Chen, Yi-Hsiang Huang, Young-Joo Jin, Dae Won Jun, Jin-Wook Kim, Neung Hwa Park, Cheng-Yuan Peng, Hyun Phil Shin, Jung Woo Shin, Yao-Hsu Yang, Young-Suk Lim. Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis. Journal of Hepatology 2023; 78(3) doi: 10.1016/j.jhep.2022.12.007
|
| 57 |
Alastair L. Young, Robert Adair, Rajendra K. Prasad, Giles J. Toogood, Peter A.J. Lodge. Hepatocellular Carcinoma Within a Noncirrhotic, Nonfibrotic, Seronegative Liver: Surgical Approaches and Outcomes. Journal of the American College of Surgeons 2012; 214(2) doi: 10.1016/j.jamcollsurg.2011.10.005
|
| 58 |
Chen-Chun Lin, Chien-Fu Hung, Wei-Ting Chen, Shi-Ming Lin. Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Impact of Early Response to 4 Weeks of Treatment. Liver Cancer 2015; 4(4) doi: 10.1159/000367737
|
| 59 |
Yu-ting Liu, Zheng-wei Mao, Yuan Ding, Wei-lin Wang. Macrophages as Targets in Hepatocellular Carcinoma Therapy. Molecular Cancer Therapeutics 2024; 23(6) doi: 10.1158/1535-7163.MCT-23-0660
|
| 60 |
Pedro L. Prieto-Hontoria, Patricia Pérez-Matute, Marta Fernández-Galilea, Matilde Bustos, J. Alfredo Martínez, María J. Moreno-Aliaga. Role of obesity-associated dysfunctional adipose tissue in cancer: A molecular nutrition approach. Biochimica et Biophysica Acta (BBA) - Bioenergetics 2011; 1807(6) doi: 10.1016/j.bbabio.2010.11.004
|
| 61 |
Anh Tuan Nguyen, Alexander Emelyanov, Chor Hui Vivien Koh, Jan M. Spitsbergen, Serguei Parinov, Zhiyuan Gong. An inducible kras
V12 transgenic zebrafish model for liver tumorigenesis and chemical drug screening. Disease Models & Mechanisms 2012; 5(1) doi: 10.1242/dmm.008367
|
| 62 |
Hung-Chih Yang, Shiou-Hwei Yeh, Pei-Jer Chen, Ding-Shinn Chen. Viruses and Human Cancer. 2014; doi: 10.1007/978-1-4939-0870-7_6
|
| 63 |
Omer Senarslan, Umut Hasan Kantarci, Mehmet Eyuboglu, Dilsad Amanvermez Senarslan. Is it possible? Invasion of the heart with hepatocellular carcinoma in a short time. International Journal of the Cardiovascular Academy 2016; 2(3) doi: 10.1016/j.ijcac.2016.06.002
|
| 64 |
Brandon M. Meyers, Jennifer J. Knox, David M. Liu, Deanna McLeod, Ravi Ramjeesingh, Vincent C. Tam, Howard J. Lim. The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma – A systematic review. Cancer Treatment Reviews 2023; 118 doi: 10.1016/j.ctrv.2023.102584
|
| 65 |
Gabriel Wcislo, Katarzyna Szarlej-Wcislo. Health of HIV Infected People. 2015; doi: 10.1016/B978-0-12-800769-3.00004-4
|
| 66 |
Marie-Pierre Lambert, Pierre-Benoit Ancey, Davide Degli Esposti, Marie-Pierre Cros, Athena Sklias, Jean-Yves Scoazec, David Durantel, Hector Hernandez-Vargas, Zdenko Herceg. Aberrant DNA methylation of imprinted loci in hepatocellular carcinoma and after in vitro exposure to common risk factors. Clinical Epigenetics 2015; 7(1) doi: 10.1186/s13148-015-0053-9
|
| 67 |
D. SAUNDERS, D. SEIDEL, M. ALLISON, G. LYRATZOPOULOS. Systematic review: the association between obesity and hepatocellular carcinoma – epidemiological evidence. Alimentary Pharmacology & Therapeutics 2010; 31(10) doi: 10.1111/j.1365-2036.2010.04271.x
|
| 68 |
Michael C. Kew. Epidemiology of hepatocellular carcinoma in sub-Saharan Africa. Annals of Hepatology 2013; 12(2) doi: 10.1016/S1665-2681(19)31354-7
|
| 69 |
Alessia Marino, Francesca Ori, Giovanni Pacioni, Marco Leonardi, Mirco Iotti. Characterization of culturable truffle-inhabiting fungi isolated from Tuber melanosporum, T. aestivum and T. borchii ascomata. Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology 2023; 157(5) doi: 10.1080/11263504.2023.2234904
|
| 70 |
Hanan M. Hassan, Mohammed Baradwan, Alaa Bagalagel, Reem Diri, Ahmed Basilim, Mohammed Z. Nasrullah, Abdulhamid Althagafi, Hussam I. Kutbi, Abdulaziz A. Mohammed, Hanan M. Alshan, Mohammed M.H. Al-Gayyar. Effect of modulating the extracellular matrix cross linkage by genipin on tumor cell resistance and survival in thioacetamide-induced hepatocellular carcinoma in rats. PeerJ 2025; 13 doi: 10.7717/peerj.19680
|
| 71 |
Basma S. Amer, Noha M. El-Anwar. Expression of osteopontin in hepatocellular carcinoma. Egyptian Journal of Pathology 2021; 41(1) doi: 10.4103/egjp.egjp_31_21
|
| 72 |
Nada Assi, Duncan C. Thomas, Michael Leitzmann, Magdalena Stepien, Véronique Chajès, Thierry Philip, Paolo Vineis, Christina Bamia, Marie-Christine Boutron-Ruault, Torkjel M. Sandanger, Amaia Molinuevo, Hendriek C. Boshuizen, Anneli Sundkvist, Tilman Kühn, Ruth C. Travis, Kim Overvad, Elio Riboli, Marc J. Gunter, Augustin Scalbert, Mazda Jenab, Pietro Ferrari, Vivian Viallon. Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case–Control Study in EPIC. Cancer Epidemiology, Biomarkers & Prevention 2018; 27(5) doi: 10.1158/1055-9965.EPI-17-0649
|
| 73 |
Thomas von Hahn, Sandra Ciesek, Gerd Wegener, Ruben R. Plentz, Tobias J. Weismüller, Heiner Wedemeyer, Michael P. Manns, Tim F. Greten, Nisar P. Malek. Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany. Scandinavian Journal of Gastroenterology 2011; 46(9) doi: 10.3109/00365521.2011.589472
|
| 74 |
Tung-Ching Ho, Er-Yea Wang, Kun-Huei Yeh, Yung-Ming Jeng, Jau-Hau Horng, Li-Ling Wu, Yi-Tzu Chen, Hsuan-Cheng Huang, Chia-Lang Hsu, Pei-Jer Chen, Shiou-Hwei Yeh, Ding-Shinn Chen. Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver. Proceedings of the National Academy of Sciences 2020; 117(12) doi: 10.1073/pnas.1918028117
|
| 75 |
Chunxiao Zhou, Qiang Yu, Lei Chen, Jian Wang, Shudan Zheng, Jinkun Zhang. A miR-1231 binding site polymorphism in the 3′UTR of IFNAR1 is associated with hepatocellular carcinoma susceptibility. Gene 2012; 507(1) doi: 10.1016/j.gene.2012.06.073
|
| 76 |
Si Yang, Yujiao Deng, Yi Zheng, Jing Zhang, Dongdong He, Zhijun Dai, Changcun Guo. Burden, trends, and predictions of liver cancer in China, Japan, and South Korea: analysis based on the Global Burden of Disease Study 2021. Hepatology International 2025; 19(2) doi: 10.1007/s12072-024-10763-6
|
| 77 |
R. CABRERA, D. R. NELSON. Review article: the management of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2010; 31(4) doi: 10.1111/j.1365-2036.2009.04200.x
|
| 78 |
Fanghua Qi, Anyuan Li, Lin Zhao, Huanli Xu, Yoshinori Inagaki, Dongliang Wang, Xiaoyan Cui, Bo Gao, Norihiro Kokudo, Munehiro Nakata, Wei Tang. Cinobufacini, an aqueous extract from Bufo bufo gargarizans Cantor, induces apoptosis through a mitochondria-mediated pathway in human hepatocellular carcinoma cells. Journal of Ethnopharmacology 2010; 128(3) doi: 10.1016/j.jep.2010.02.022
|
| 79 |
Monika Moser, Iuliana‐Pompilia Radu, Jean‐François Dufour. Effects of Home Care on patients with hepatocellular carcinoma treated with sorafenib. JGH Open 2021; 5(8) doi: 10.1002/jgh3.12533
|
| 80 |
Fengju OuYang, Guibin Wang, Wei Guo, Yuanyuan Zhang, Wenhua Xiang, Min Zhao. AKT signalling and mitochondrial pathways are involved in mushroom polysaccharide-induced apoptosis and G1 or S phase arrest in human hepatoma cells. Food Chemistry 2013; 138(4) doi: 10.1016/j.foodchem.2012.10.047
|
| 81 |
Prabu Thangavel, Ragunath Muthu, Manju Vaiyapuri. Antioxidant potential of naringin – a dietary flavonoid – in N-Nitrosodiethylamine induced rat liver carcinogenesis. Biomedicine & Preventive Nutrition 2012; 2(3) doi: 10.1016/j.bionut.2012.03.006
|
| 82 |
Chuan-Ping Feng, Hai-Ming Tang, Song Huang, Shao-Zhen Hou, Jian Liang, Wei Huang, Xiao-Ping Lai. Evaluation of the effects of the water-soluble total flavonoids from Isodon lophanthoides var.gerardianus (Benth.) H. Hara on apoptosis in HepG2 cell: Investigation of the most relevant mechanisms. Journal of Ethnopharmacology 2016; 188 doi: 10.1016/j.jep.2016.04.042
|
| 83 |
Min-Ae Song, Maarit Tiirikainen, Sandi Kwee, Gordon Okimoto, Herbert Yu, Linda L. Wong, Alejandro H. Corvalan. Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma. PLoS ONE 2013; 8(2) doi: 10.1371/journal.pone.0055761
|
| 84 |
Arig Aly Seif, Heba Hassan Aly, Doaa Mostafa Elzoghby, Ashraf Mohammed Elbreedy, Mohamed Lotfy. Aberrant p16 methylation as an early diagnostic marker in blood of hepatocellular carcinoma patients. Egyptian Journal of Medical Human Genetics 2019; 20(1) doi: 10.1186/s43042-019-0027-0
|
| 85 |
Ashish Goyal, John M. Murray, Yury E. Khudyakov. The Impact of Vaccination and Antiviral Therapy on Hepatitis B and Hepatitis D Epidemiology. PLoS ONE 2014; 9(10) doi: 10.1371/journal.pone.0110143
|
| 86 |
Omar A. Saldarriaga, Bradley Dye, Judy Pham, Timothy G. Wanninger, Daniel Millian, Michael Kueht, Benjamin Freiberg, Netanya Utay, Heather L. Stevenson. Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93881-7
|
| 87 |
Marthandam Asokan Shibu, Yi‐Ju Chen, Hong‐Siang Yang, Yen‐Hua He, Yun‐Hsin Lo, Wan‐Teng Lin. Principle active metabolites of Pinus morrisonicolaHayata synergistically inhibit cell proliferation and autophagy to elevate apoptosis in hepatocellular carcinoma cells. Environmental Toxicology 2023; 38(12) doi: 10.1002/tox.23935
|
| 88 |
Kurt Sartorius, Julia Makarova, Benn Sartorius, Ping An, Cheryl Winkler, Anil Chuturgoon, Anna Kramvis. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019; 8(12) doi: 10.3390/cells8121504
|
| 89 |
Noriyuki Kitagawa, Hidenori Ojima, Takuya Shirakihara, Hiroko Shimizu, Akiko Kokubu, Tomoko Urushidate, Yasushi Totoki, Tomoo Kosuge, Shinichi Miyagawa, Tatsuhiro Shibata. Downregulation of the microRNA biogenesis components and its association with poor prognosis in hepatocellular carcinoma. Cancer Science 2013; 104(5) doi: 10.1111/cas.12126
|
| 90 |
Yuri Cho, Eun Ju Cho, Jeong-Ju Yoo, Young Chang, Goh Eun Chung, In Young Choi, Sang-Hyun Park, Kyungdo Han, Yoon Jun Kim, Jung-Hwan Yoon, Dong Wook Shin, Su Jong Yu. The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.863352
|
| 91 |
Xin Deng, Xiao fang Zhao, Xing qiu Liang, Ran Chen, Yi feng Pan, Jian Liang. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2017; 90 doi: 10.1016/j.biopha.2017.03.031
|
| 92 |
Jing Gao, Li Xie, Wan-Shui Yang, Wei Zhang, Shan Gao, Jing Wang, Yong-Bing Xiang. Risk Factors of Hepatocellular Carcinoma - Current Status and Perspectives. Asian Pacific Journal of Cancer Prevention 2012; 13(3) doi: 10.7314/APJCP.2012.13.3.743
|
| 93 |
Tanecia Mitchell, Balu Chacko, Scott W. Ballinger, Shannon M. Bailey, Jianhua Zhang, Victor Darley-Usmar. Convergent mechanisms for dysregulation of mitochondrial quality control in metabolic disease: implications for mitochondrial therapeutics. Biochemical Society Transactions 2013; 41(1) doi: 10.1042/BST20120231
|
| 94 |
Nasim Habibi, Mohsen Nassiri-Toosi, Heidar Sharafi, Seyed Moayed Alavian, Masoomeh Shams-Ghahfarokhi, Mehdi Razzaghi-Abyaneh. Aflatoxin B1 exposure and the risk of hepatocellular carcinoma in Iranian carriers of viral hepatitis B and C. Toxin Reviews 2019; 38(3) doi: 10.1080/15569543.2018.1446027
|
| 95 |
Lu Shun Zhang, Fang Yuan, Xuan Guan, Juan Li, Xin Lian Liu, Jing Sun, Bo Liu, Wei Ma, Feng Mei Deng. Association of Genetic Polymorphisms in HSD17B1, HSD17B2 and SHBG Genes with Hepatocellular Carcinoma Risk. Pathology & Oncology Research 2014; 20(3) doi: 10.1007/s12253-014-9746-1
|
| 96 |
Yuanshun Zhao, Yonghong Zhang, Dongdong Lin, Kang Li, Chengzeng Yin, Xiuhong Liu, Boxun Jin, Libo Sun, Jinhua Liu, Aiying Zhang, Ning Li. Protein microarray with horseradish peroxidase chemiluminescence for quantification of serum α-fetoprotein. Journal of International Medical Research 2015; 43(5) doi: 10.1177/0300060515583075
|
| 97 |
Rou Li, Danni Li, Guorong Jia, Xiao Li, Gaofeng Sun, Changjing Zuo. Diagnostic Performance of Theranostic Radionuclides Used in Transarterial Radioembolization for Liver Cancer. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.551622
|
| 98 |
Iván Lyra-González, Laura Esther Flores-Fong, Ignacio González-García, David Medina-Preciado, Juan Armendáriz-Borunda. Adenoviral gene therapy in hepatocellular carcinoma: a review. Hepatology International 2013; 7(1) doi: 10.1007/s12072-012-9367-2
|
| 99 |
Chun-Man Lee, Benedetto Natalini. A Review on the Antimutagenic and Anticancer Effects of Cysteamine. Advances in Pharmacological and Pharmaceutical Sciences 2023; 2023 doi: 10.1155/2023/2419444
|
| 100 |
Jin Lee, Kye‐Taek Lim. Phytoglycoprotein (38 kDa) induces cell cycle (G0/G1) arrest and apoptosis in HepG2 cells. Journal of Cellular Biochemistry 2011; 112(11) doi: 10.1002/jcb.23239
|
| 101 |
Arnolfo Petruzziello. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma. The Open Virology Journal 2018; 12(1) doi: 10.2174/1874357901812010026
|
| 102 |
Christopher Koh, T. Jake Liang. Settling the “score” with liver cancer. Journal of Hepatology 2009; 50(1) doi: 10.1016/j.jhep.2008.10.008
|
| 103 |
Kimia Falamarzi, Mahdi Malekpour, Mobin Fallah Tafti, Negar Azarpira, Mehrdad Behboodi, Mohammad Zarei. The role of FGF21 and its analogs on liver associated diseases. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.967375
|
| 104 |
Daria Apostolo, Luciana L. Ferreira, Federica Vincenzi, Nicole Vercellino, Rosalba Minisini, Federico Latini, Barbara Ferrari, Michela E. Burlone, Mario Pirisi, Mattia Bellan. From MASH to HCC: the role of Gas6/TAM receptors. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1332818
|
| 105 |
Marius Farcas, Andrei-Alexandru Gavrea, Diana Gulei, Calin Ionescu, Alexandru Irimie, Cristina S. Catana, Ioana Berindan-Neagoe. SIRT1 in the Development and Treatment of Hepatocellular Carcinoma. Frontiers in Nutrition 2019; 6 doi: 10.3389/fnut.2019.00148
|
| 106 |
Yashasavi Sachar, Mayur Brahmania, Renumathy Dhanasekaran, Stephen E. Congly. Screening for Hepatocellular Carcinoma in Patients with Hepatitis B. Viruses 2021; 13(7) doi: 10.3390/v13071318
|
| 107 |
Claire E. Thomas, Hung N. Luu, Renwei Wang, Guoxiang Xie, Jennifer Adams-Haduch, Aizhen Jin, Woon-Puay Koh, Wei Jia, Jaideep Behari, Jian-Min Yuan. Association between Pre-Diagnostic Serum Bile Acids and Hepatocellular Carcinoma: The Singapore Chinese Health Study. Cancers 2021; 13(11) doi: 10.3390/cancers13112648
|
| 108 |
Lee Jin Lim, Samuel Y.S. Wong, Feiyang Huang, Sheng Lim, Samuel S. Chong, London Lucien Ooi, Oi Lian Kon, Caroline G. Lee. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma. Cancer Research 2019; 79(20) doi: 10.1158/0008-5472.CAN-19-0255
|
| 109 |
Deepika Divya Kadiri, Sujatha Peela, Debayan Ganguli. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; doi: 10.1016/B978-0-323-98806-3.00002-7
|
| 110 |
Catherine Yujia Gu, Terence Kin Wah Lee. Preclinical mouse models of hepatocellular carcinoma: An overview and update. Experimental Cell Research 2022; 412(2) doi: 10.1016/j.yexcr.2022.113042
|
| 111 |
Patrick Ying-Kit Yue, Yi-Yi Wong, Kay Yuen-Ki Wong, Yeuk-Ki Tsoi, Kelvin Sze-Yin Leung. Current evidence for the hepatoprotective activities of the medicinal mushroom Antrodia cinnamomea. Chinese Medicine 2013; 8(1) doi: 10.1186/1749-8546-8-21
|
| 112 |
Somsak Likhitrattanapisal, Jaitip Tipanee, Tavan Janvilisri. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma. Tumor Biology 2016; 37(9) doi: 10.1007/s13277-016-5186-8
|
| 113 |
Asmaa Ashraf Mohamed, Monica Armanious, Rana W. Bedair, Nada Sherif Amin, Hend M. El Tayebi. When less is more: The association between the expression of polymorphic CYPs and AFB1‐induced HCC. European Journal of Clinical Investigation 2024; 54(12) doi: 10.1111/eci.14297
|
| 114 |
Yefan Zhu, Liang Zhao, Keqing Shi, Zitao Huang, Bicheng Chen. TRIM24 promotes hepatocellular carcinoma progression via AMPK signaling. Experimental Cell Research 2018; 367(2) doi: 10.1016/j.yexcr.2018.04.006
|
| 115 |
Jin Mi Chun, Kyoung Jin Nho, A. Yeong Lee, Byeong Cheol Moon, Jun Yeon Park, Ho Kyoung Kim. A methanol fraction from Chaenomeles sinensis inhibits hepatocellular carcinoma growth in vitro and in vivo. Journal of the Korean Society for Applied Biological Chemistry 2012; 55(3) doi: 10.1007/s13765-012-1043-7
|
| 116 |
. 2011; doi: 10.70675/017295bcz4478z462bz8c30zc84677e13de0
|
| 117 |
Fei Chen, Kevin Beezhold, Vince Castranova. JNK1, a potential therapeutic target for hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2009; 1796(2) doi: 10.1016/j.bbcan.2009.06.005
|
| 118 |
Maha Alhelf, Rasha M. S. Shoaib, Afaf Elsaid, Nermeen Bastawy, Nanis S. Elbeltagy, Eman T. Salem, Sherif Refaat, Eman H. Abuelnadar. Prognostic significance of the genetic variant of lymphotoxin alpha (p.Thr60Asn) in egyptian patients with advanced hepatocellular carcinoma. Molecular Biology Reports 2023; 50(5) doi: 10.1007/s11033-023-08281-z
|
| 119 |
Imam Waked, Sherif Alsammany, Sayed Hammad Tirmazy, Kakil Rasul, Jafar Bani‐Issa, Wael Abdel‐Razek, Ashraf Omar, Amr Shafik, Salem Eid, Amr Abdelaal, Ahmed Hosni, Gamal Esmat. Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region. Liver International 2023; 43(10) doi: 10.1111/liv.15685
|
| 120 |
L.M. Stoffels, E.S. Espinoza Rodriguez, J. Theys, R. Shiri-Sverdlov. Revisiting cholesterol metabolism in hepatocellular carcinoma: a hidden driver of systemic therapy response. ESMO Gastrointestinal Oncology 2026; 11 doi: 10.1016/j.esmogo.2025.100284
|
| 121 |
Jian-zhong Di, Xiao-dong Han, Wen-ye Gu, Yu Wang, Qi Zheng, Pin Zhang, Hui-min Wu, Zhong-zheng Zhu. Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma. Journal of Zhejiang University SCIENCE B 2011; 12(10) doi: 10.1631/jzus.B1000422
|
| 122 |
Yu-Chiau Shyu, Tung-Liang Lee, Mu-Jie Lu, Jim-Ray Chen, Rong-Nan Chien, Huang-Yang Chen, Ji-Fan Lin, Ann-Ping Tsou, Yu-Hsien Chen, Chia-Wen Hsieh, Ting-Shuo Huang. miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma. Journal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-0956-z
|
| 123 |
B. J. VENNERVALD, K. POLMAN. Helminths and malignancy. Parasite Immunology 2009; 31(11) doi: 10.1111/j.1365-3024.2009.01163.x
|
| 124 |
Jingwang Bi, Chen Zhong, Kainan Li, Huili Chu, Baocheng Wang. Association Study of Single Nucleotide Polymorphisms inXRCC1Gene with Risk of Hepatocellular Carcinoma in Chinese Han Population. BioMed Research International 2013; 2013 doi: 10.1155/2013/138785
|
| 125 |
Zeyu Zhang, Yufan Zhou, Jiajin Yang, Kuan Hu, Yun Huang. The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5735-9
|
| 126 |
Dawn Qingqing Chong, Iain Beehuat Tan, Su-Pin Choo, Han Chong Toh. The evolving landscape of therapeutic drug development for hepatocellular carcinoma. Contemporary Clinical Trials 2013; 36(2) doi: 10.1016/j.cct.2013.03.013
|
| 127 |
Magdalena Stepien, David J Hughes, Sandra Hybsier, Christina Bamia, Anne Tjønneland, Kim Overvad, Aurélie Affret, Mathilde His, Marie-Christine Boutron-Ruault, Verena Katzke, Tilman Kühn, Krasimira Aleksandrova, Antonia Trichopoulou, Pagona Lagiou, Phlippos Orfanos, Domenico Palli, Sabina Sieri, Rosario Tumino, Fulvio Ricceri, Salvatore Panico, H B(as) Bueno-de-Mesquita, Petra H Peeters, Elisabete Weiderpass, Cristina Lasheras, Catalina Bonet Bonet, Elena Molina-Portillo, Miren Dorronsoro, José María Huerta, Aurelio Barricarte, Bodil Ohlsson, Klas Sjöberg, Mårten Werner, Dmitry Shungin, Nick Wareham, Kay-Tee Khaw, Ruth C Travis, Heinz Freisling, Amanda J Cross, Lutz Schomburg, Mazda Jenab. Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans. British Journal of Cancer 2017; 116(5) doi: 10.1038/bjc.2017.1
|
| 128 |
Dorra Trad, Norsaf Bibani, Meriam Sabbah, Hela Elloumi, Dalila Gargouri, Asma Ouakaa, Jamel Kharrat. Known, new and emerging risk factors of hepatocellular carcinoma (review). La Presse Médicale 2017; 46(11) doi: 10.1016/j.lpm.2017.09.025
|
| 129 |
. 2019; doi: 10.70675/f23f0221zd53ez41a4za07cz79c8f84bf6de
|
| 130 |
Chien-Hsin Chang, Tur-Fu Huang, Kung-Tin Lin, Chun-Chieh Hsu, Wei-Luen Chang, Shih-Wei Wang, Feng-Nien Ko, Hui-Chin Peng, Ching-Hu Chung. 4-Acetylantroquinonol B Suppresses Tumor Growth and Metastasis of Hepatoma Cells via Blockade of Translation-Dependent Signaling Pathway and VEGF Production. Journal of Agricultural and Food Chemistry 2015; 63(1) doi: 10.1021/jf504434v
|
| 131 |
Jie Liu, Guo-Zheng Yu, Xiao-Ke Cheng, Xiao-Dong Li, Xian-Tao Zeng, Xue-Qun Ren. LGR5 promotes hepatocellular carcinoma metastasis through inducting epithelial-mesenchymal transition. Oncotarget 2017; 8(31) doi: 10.18632/oncotarget.15143
|
| 132 |
Akanksha Sharma, Ananya Shukla, Kriti Attri, Megha Kumar, Puneet Kumar, Ashish Suttee, Gurpal Singh, Ravi Pratap Barnwal, Neha Singla. Global trends in pesticides: A looming threat and viable alternatives. Ecotoxicology and Environmental Safety 2020; 201 doi: 10.1016/j.ecoenv.2020.110812
|
| 133 |
. 2024; doi: 10.70675/9e425f1az4073z44bczbd26zf68305a8ab69
|
| 134 |
Chibo Liu, Haibao Wang, Chunqin Pan, Jianmin Shen, Yong Liang. CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls. Tumor Biology 2012; 33(4) doi: 10.1007/s13277-012-0326-2
|
| 135 |
|
| 136 |
Michele T. Yip-Schneider, Patrick J. Klein, Sabrina C. Wentz, Amer Zeni, Alex Menze, C. Max Schmidt. Resistance to Mitogen-Activated Protein Kinase Kinase (MEK) Inhibitors Correlates with Up-Regulation of the MEK/Extracellular Signal-Regulated Kinase Pathway in Hepatocellular Carcinoma Cells. The Journal of Pharmacology and Experimental Therapeutics 2009; 329(3) doi: 10.1124/jpet.108.147306
|
| 137 |
Runzhou Zhuang, Xuanyu Zhang, Di Lu, Jianguo Wang, Jianyong Zhuo, Xuyong Wei, Qi Ling, Haiyang Xie, Shusen Zheng, Xiao Xu. lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c‐Myb‐regulated MEK/ERK signaling. Molecular Carcinogenesis 2019; 58(3) doi: 10.1002/mc.22934
|
| 138 |
Mohamad H. Imam, Marina G. Silveira, Emmanouil Sinakos, Andrea A. Gossard, Roberta Jorgensen, Jill Keach, Alisha C. DeCook, Keith D. Lindor. Long-term Outcomes of Patients With Primary Biliary Cirrhosis and Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology 2012; 10(2) doi: 10.1016/j.cgh.2011.09.013
|
| 139 |
Bin Sui, Jun Lv, Xiangrong Tong, Yan Li, Chengyan Wang. Simultaneous image reconstruction and lesion segmentation in accelerated MRI using multitasking learning. Medical Physics 2021; 48(11) doi: 10.1002/mp.15213
|
| 140 |
Lok-Sze Wong, Chun-Ming Wong. Decoding the Roles of Long Noncoding RNAs in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(6) doi: 10.3390/ijms22063137
|
| 141 |
Eva Sticova, Milan Jirsa. ABCB4 disease: Many faces of one gene deficiency. Annals of Hepatology 2020; 19(2) doi: 10.1016/j.aohep.2019.09.010
|
| 142 |
Aysegul Ozakyol. Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology). Journal of Gastrointestinal Cancer 2017; 48(3) doi: 10.1007/s12029-017-9959-0
|
| 143 |
Hany A. Abdel Samie, Mohd Saeed, Syed Mohd Faisal, Mohd Adnan Kausar, Mohammad A. Kamal. Recent Findings on Nanotechnology-based Therapeutic Strategies Against Hepatocellular Carcinoma. Current Drug Metabolism 2019; 20(4) doi: 10.2174/1389200220666190308134351
|
| 144 |
Zhicong Zhao, Zhenjun Zhao, Jianye Wang, He Zhang, Zhifeng Xi, Qiang Xia. ABCC6 Knockdown Fuels Cell Proliferation by Regulating PPARα in Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.840287
|
| 145 |
Jaleh Varshosaz, Maryam Farzan. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12022-12041 doi: 10.3748/wjg.v21.i42.12022
|
| 146 |
Riti Tushar Kanti Sinha, Aniruna Dey, Seema Agarwal. Initial presentation of hepatocellular carcinoma as soft tissue swelling of the forearm: A rare cytomorphological diagnosis. Journal of Cancer Research and Therapeutics 2015; 11(4) doi: 10.4103/0973-1482.154052
|
| 147 |
Kazuhito Ichikawa, Yoshiaki Tagawa, Masaomi Kawai, Makoto Asamoto, Tomoyuki Shirai. Promoting Effects of Streptozotocin-induced Diabetes on Induction of Hepatic Preneoplastic Lesions by Diethylnitrosamine in Rats. Journal of Toxicologic Pathology 2010; 23(3) doi: 10.1293/tox.23.125
|
| 148 |
Yuting Wu, Yingshi Zhang, Xiaochun Qin, Haobin Geng, Daiying Zuo, Qingchun Zhao. PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma. Pharmacological Research 2020; 160 doi: 10.1016/j.phrs.2020.105195
|
| 149 |
Chang Hun Lee, Min Gu Kang, Shinyoung Oh, In Sun Goak, Chen Shen, Ha Ram Oh, Young Ran Park, Jong Seung Kim, Ji Hyun Park. Hepatocellular carcinoma risk in ICD-coded non-cirrhotic nonalcoholic fatty liver disease refined by fatty liver index: A nationwide South Korean cohort study. Clinics and Research in Hepatology and Gastroenterology 2025; 49(6) doi: 10.1016/j.clinre.2025.102612
|
| 150 |
Katsuhiro Ogawa. Molecular pathology of early stage chemically induced hepatocarcinogenesis. Pathology International 2009; 59(9) doi: 10.1111/j.1440-1827.2009.02416.x
|
| 151 |
Eric J. Formeister, Masato Tsuchiya, Hideki Fujii, Svitlana Shpyleva, Igor P. Pogribny, Ivan Rusyn. Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2010; 692(1-2) doi: 10.1016/j.mrfmmm.2010.07.013
|
| 152 |
Luca Quagliata, Luigi M. Terracciano. Liver Diseases and Long Non-Coding RNAs: New Insight and Perspective. Frontiers in Medicine 2014; 1 doi: 10.3389/fmed.2014.00035
|
| 153 |
Fa-Da Xia, Zhuo-Lu Wang, Hong-Xi Chen, Yun Huang, Jin-Dong Li, Zhi-Ming Wang, Xin-Ying Li. Differential Expression of IQGAP1/2 in Hepatocellular Carcinoma and its Relationship with Clinical Outcomes. Asian Pacific Journal of Cancer Prevention 2014; 15(12) doi: 10.7314/APJCP.2014.15.12.4951
|
| 154 |
Véronique S. Zongo, Yumei Zhou, Florencia W. Djigma, Emile Roamba, Albert T. Yonli, Abel P. Sorgho, Oumar Barro, Sosthene K. Somda, Tegwinde R. Compaore, Mahamoudou Sanou, Jeremy J. Martinson, Lassina Traore, Jean Christopher Chamcheu, Jacob K. Zongo, Olga M. Lompo, Lewis R. Roberts, Mitesh J. Borad, Bolni M. Nagalo, Jacques K. Simpore. Identification of Novel TERT Promoter Mutations in Chronic Hepatitis B-Induced HCC Patients in Burkina Faso. American Journal of Molecular Biology 2026; 16(01) doi: 10.4236/ajmb.2026.161004
|
| 155 |
Kan Toriguchi, Etsuro Hatano, Kazutaka Tanabe, Kenji Takemoto, Kojiro Nakamura, Yukinori Koyama, Satoru Seo, Kojiro Taura, Shinji Uemoto. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine‐choline deficient diet by CCAAT/enhancer‐binding protein homologous protein deficiency. Journal of Gastroenterology and Hepatology 2014; 29(5) doi: 10.1111/jgh.12481
|
| 156 |
Noora Kano, Elizabeth J. Want, Mark J. W. McPhail. Metabolomics in Advanced Liver Disease. Current Treatment Options in Gastroenterology 2021; 19(2) doi: 10.1007/s11938-021-00347-w
|
| 157 |
Jin-yan Zhao, Wei Lin, Qun-chuan Zhuang, Xiao-yong Zhong, Jun Peng, Zhen-Feng Hong. Bear bile powder inhibits angiogenesis in vivo and in vitro. Chinese Journal of Integrative Medicine 2015; 21(5) doi: 10.1007/s11655-015-2062-0
|
| 158 |
Deepali Jain, Nabeen C. Nayak, Sanjiv Saigal. Hepatocellular carcinoma in nonalcoholic fatty liver cirrhosis and alcoholic cirrhosis. European Journal of Gastroenterology & Hepatology 2012; 24(7) doi: 10.1097/MEG.0b013e3283534b40
|
| 159 |
E. Innala, C. Andersson. Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden. Journal of Internal Medicine 2011; 269(5) doi: 10.1111/j.1365-2796.2010.02335.x
|
| 160 |
Daokun Yang, Fujun Zhou, Xinwei Wang, Haili Gao, Guangyan Li, Minghui Xue. Association analysis betweenMDR1gene polymorphisms and risk of hepatocellular carcinoma in Chinese population. Biomarkers 2013; 18(3) doi: 10.3109/1354750X.2013.773079
|
| 161 |
Jiao Li, Dan-Dan Wu, Ji-Xiang Zhang, Jing Wang, Jing-Jing Ma, Xue Hu, Wei-Guo Dong. Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells. World Journal of Gastroenterology 2018; 24(17): 1901-1910 doi: 10.3748/wjg.v24.i17.1901
|
| 162 |
Kyuwoong Kim, Seulggie Choi, Sang Min Park. Association of fasting serum glucose level and type 2 diabetes with hepatocellular carcinoma in men with chronic hepatitis B infection: A large cohort study. European Journal of Cancer 2018; 102 doi: 10.1016/j.ejca.2018.07.008
|
| 163 |
Alexander Gerbes, Fabien Zoulim, Herbert Tilg, Jean-François Dufour, Jordi Bruix, Valérie Paradis, Riad Salem, Markus Peck-Radosavljevic, Peter R Galle, Tim F Greten, Jean-Charles Nault, Matias A Avila. Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut 2018; 67(2) doi: 10.1136/gutjnl-2017-315068
|
| 164 |
Hao Zheng, Wei-hua Jiang, Tao Tian, Hai-song Tan, Ying Chen, Guang-lei Qiao, Jun Han, Sheng-yu Huang, Yuan Yang, Shuai Li, Zhen-guang Wang, Rong Gao, Hao Ren, Hao Xing, Jun-sheng Ni, Lin-Hui Wang, Li-jun Ma, Wei-ping Zhou. CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma. Oncotarget 2017; 8(12) doi: 10.18632/oncotarget.14770
|
| 165 |
Ruili Li, Hongjun Li, Yanyan Zhang, Qi Zhang, Jinli Ding, Yunfang Li. Study progression MRI findings with pathologic correlation in hepatitis B virus-associated multistage hepatocellular carcinoma. Radiology of Infectious Diseases 2015; 2(2) doi: 10.1016/j.jrid.2015.08.001
|
| 166 |
Daniel Ansari, Inger Keussen, Roland Andersson. Positron emission tomography in malignancies of the liver, pancreas and biliary tract – indications and potential pitfalls. Scandinavian Journal of Gastroenterology 2013; 48(3) doi: 10.3109/00365521.2012.704936
|
| 167 |
Ambreen Ayub, Usman Ali Ashfaq, Asma Haque. HBV Induced HCC: Major Risk Factors from Genetic to Molecular Level. BioMed Research International 2013; 2013 doi: 10.1155/2013/810461
|
| 168 |
Nadia Panera, Annalisa Crudele, Ilaria Romito, Daniela Gnani, Anna Alisi. Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2017; 18(1) doi: 10.3390/ijms18010099
|
| 169 |
Diwakar Suresh, Akshatha N. Srinivas, Bharathwaaj Gunaseelan, S.A. Amith Bharadwaj, Manju Moorthy, Gopalkrishna Ramaswamy, Suchitha Satish, Prashant Vishwanath, Prasanna Kumar Santhekadur, Saravana Babu Chidambaram, Divya P. Kumar. Targeting AATF reprograms the tumor microenvironment and suppresses hepatocellular carcinoma via MIR100HG-TGF-β signaling. Molecular Therapy Oncology 2026; 34(3) doi: 10.1016/j.omton.2026.201259
|
| 170 |
. 2010; doi: 10.70675/67431327z2d66z4377zbccfz54595bf855e3
|
| 171 |
Peter I. Chater, Matthew D. Wilcox, Jeffrey P. Pearson, Iain A. Brownlee. The impact of dietary fibres on the physiological processes governing small intestinal digestive processes. Bioactive Carbohydrates and Dietary Fibre 2015; 6(2) doi: 10.1016/j.bcdf.2015.09.002
|
| 172 |
Daniel da Motta Girardi, Tatiana Strava Correa, Marcela Crosara Teixeira, Gustavo Dos Santos Fernandes. Hepatocellular Carcinoma: Review of Targeted and Immune Therapies. Journal of Gastrointestinal Cancer 2018; 49(3) doi: 10.1007/s12029-018-0121-4
|
| 173 |
Ying Xie, Shufeng Liu, Yue Zhao, Zhanjun Guo, Jinsheng Xu. X protein mutations in hepatitis B virus DNA predict postoperative survival in hepatocellular carcinoma. Tumor Biology 2014; 35(10) doi: 10.1007/s13277-014-2331-0
|
| 174 |
Nahid T. Movaghar, Saber Mojarrad, Hadi R. Shahraki, Mohammadreza Nazari, Mahtab Hadadi, Mohammad Motamedifar. Seroprevalence of Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses in End-Stage Renal Disease Patients, Southern Iran. Current Immunology Reviews 2020; 16(1) doi: 10.2174/1573395516999200819164045
|
| 175 |
Michael C. Kew. Hepatic Iron Overload and Hepatocellular Carcinoma. Liver Cancer 2014; 3(1) doi: 10.1159/000343856
|
| 176 |
T. Ciuleanu, I. Bazin, D. Lungulescu, L. Miron, I. Bondarenko, A. Deptala, M. Rodriguez-Torres, B. Giantonio, N.L. Fox, P. Wissel, J. Egger, M. Ding, R.N. Kalyani, R. Humphreys, M. Gribbin, W. Sun. A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma. Annals of Oncology 2016; 27(4) doi: 10.1093/annonc/mdw004
|
| 177 |
Yang Song, Shou-Jie Jin, Lian-Hua Cui, Xiao-Jun Ji, Fu-Guo Yang. Immunomodulatory Effect of Stichopus japonicus Acid Mucopolysaccharide on Experimental Hepatocellular Carcinoma in Rats. Molecules 2013; 18(6) doi: 10.3390/molecules18067179
|
| 178 |
Su-Liang Chen, Yong Seng Low, Bo-Ru Huang, Che-Hao Lu, Wei-Chun Lan, Ren-Huang Wu, Hsing-Ying Lin, Andrew Yueh, En-Chi Hsu. Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma. Cancers 2026; 18(7) doi: 10.3390/cancers18071086
|
| 179 |
Cynthia Ju, Sean P. Colgan, Holger K. Eltzschig. Hypoxia-inducible factors as molecular targets for liver diseases. Journal of Molecular Medicine 2016; 94(6) doi: 10.1007/s00109-016-1408-1
|
| 180 |
Sara Ashtari, Mohamad Amin Pourhoseingholi, Afsaneh Sharifian, Mohamad Reza Zali. Hepatocellular carcinoma in Asia: Prevention strategy and planning. World Journal of Hepatology 2015; 7(12): 1708-1717 doi: 10.4254/wjh.v7.i12.1708
|
| 181 |
Hitoshi Maruyama, Masanori Takahashi, Tadashi Sekimoto, Hidehiro Kamesaki, Taro Shimada, Fumihiko Kanai, Osamu Yokosuka. Heterogeneity of Microbubble Accumulation: A Novel Approach to Discriminate Between Well-Differentiated Hepatocellular Carcinomas and Regenerative Nodules. Ultrasound in Medicine & Biology 2012; 38(3) doi: 10.1016/j.ultrasmedbio.2011.12.006
|
| 182 |
Blaise K-Kutala, Pierre Bedossa, Jeremie Guedj, Tarik Asselah, Michelle Martinot-Peignoux, Xavier Duval, Patrick Marcellin. Patients with chronic hepatitis C without advanced fibrosis and hepatocellular carcinoma: A retrospective clinical–pathological study. Digestive and Liver Disease 2015; 47(4) doi: 10.1016/j.dld.2014.12.010
|
| 183 |
Mithun Rudrapal, Aniket P. Kothawade, Shahira M. Ezzat, Chukwuebuka Egbuna. Analytical Techniques in Biosciences. 2022; doi: 10.1016/B978-0-12-822654-4.00002-6
|
| 184 |
Jin-Soo Yoon, Hwa-Mi Kim, Anandam Kasin Yadunandam, Nan-Hee Kim, Hyun-Ah Jung, Jae-Sue Choi, Chi-Yeon Kim, Gun-Do Kim. Neferine isolated from Nelumbo nucifera enhances anti-cancer activities in Hep3B cells: Molecular mechanisms of cell cycle arrest, ER stress induced apoptosis and anti-angiogenic response. Phytomedicine 2013; 20(11) doi: 10.1016/j.phymed.2013.03.024
|
| 185 |
Seogsong Jeong, Yun Hwan Oh, Joseph C Ahn, Seulggie Choi, Sun Jae Park, Hye Jun Kim, Gyeongsil Lee, Joung Sik Son, Heejoon Jang, Dong Hyeon Lee, Meng Sha, Lei Chen, Won Kim, Sang Min Park. Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study. Clinical and Molecular Hepatology 2024; 30(3) doi: 10.3350/cmh.2024.0145
|
| 186 |
Adjoa Anyane-Yeboa, Charmaine A. Stewart. A Review of Non-Alcoholic Fatty Liver Disease: From Obesity to Liver Transplant. Canadian Journal of General Internal Medicine 2015; 10(3) doi: 10.22374/cjgim.v10i3.53
|
| 187 |
Mohamed-Naguib Wifi, Rania A. Zayed, Nevine Fouad, Ahmed Y. Hassan, Maha A. Hussien, Mohamed G. Sokar. Association of serum growth differentiation factor 15 and hepatocellular carcinoma in Egyptian patients. The Egyptian Journal of Internal Medicine 2019; 31(1) doi: 10.4103/ejim.ejim_39_18
|
| 188 |
Maya Venkataramani, Nancy Hutton, Paul Colombani, Robert A. Anders, Allison L. Agwu. Hepatocellular Carcinoma in a Teenager with Perinatally Acquired HIV Infection without Hepatitis B or C Coinfection: A Case Report. AIDS Patient Care and STDs 2010; 24(11) doi: 10.1089/apc.2010.0038
|
| 189 |
Gyula Végső, Dénes Görög, Imre Fehérvári, Balázs Nemes, Attila Doros, Róbert Miklós Langer, László Kóbori. Role of Organ Transplantation in the Treatment of Malignancies – Hepatocellular Carcinoma as the Most Common Tumour Treated with Transplantation. Pathology & Oncology Research 2012; 18(1) doi: 10.1007/s12253-011-9441-4
|
| 190 |
Ji-Yeon Lee, Suk-Yong Jang, Chung Mo Nam, Eun Seok Kang. Incident Hepatocellular Carcinoma Risk in Patients Treated with a Sulfonylurea: A Nationwide, Nested, Case-Control Study. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-44447-1
|
| 191 |
Jing Tong, Yongci Tan, Wenwen Ouyang, Haocai Chang. Targeting immune checkpoints in hepatocellular carcinoma therapy: toward combination strategies with curative potential. Experimental Hematology & Oncology 2025; 14(1) doi: 10.1186/s40164-025-00636-5
|
| 192 |
Eun‐Ran Park, Sang‐Bum Kim, Jee‐San Lee, Yang‐Hyun Kim, Dong‐Hyoung Lee, Eung‐Ho Cho, Sun‐Hoo Park, Chul Ju Han, Bu‐Yeo Kim, Dong Wook Choi, Young Do Yoo, Ami Yu, Jae Won Lee, Ja June Jang, Young Nyun Park, Kyung‐Suk Suh, Kee‐Ho Lee. The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma. Cancer Medicine 2017; 6(4) doi: 10.1002/cam4.1042
|
| 193 |
Dennis Amojuaji Ndububa, Fatimah Biade Abdulkareem, Shettima Kagu Mustapha, Christopher N Ekwunife, Casimir Erhunmwun Omuemu. Soghin clinical practice guidelines for hepatocellular carcinoma. Nigerian Journal of Gastroenterology and Hepatology 2023; 15(1) doi: 10.4103/njgh.njgh_6_23
|
| 194 |
|
| 195 |
Robert Vincent, Arun Sanyal. Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players. Current Pathobiology Reports 2014; 2(3) doi: 10.1007/s40139-014-0049-8
|
| 196 |
Farida Amutova, Stefan Jurjanz, Nurlan Akhmetsadykov, Maira Kazankapova, Angelina Razafitianamaharavo, Aurélien Renard, Moldir Nurseitova, Gaukhar Konuspayeva, Matthieu Delannoy. Adsorption of organochlorinated pesticides: Adsorption kinetic and adsorption isotherm study. Results in Engineering 2023; 17 doi: 10.1016/j.rineng.2022.100823
|
| 197 |
Data efficient deep learning for liver and liver tumor segmentation: A comprehensive survey. Neurocomputing 2026; 663 doi: 10.1016/j.neucom.2025.131937
|
| 198 |
Han Jak Ryu, Do Young Kim, Jun Yong Park, Hye Young Chang, Myoung Ha Lee, Kwang‐Hyub Han, Chae Yoon Chon, Sang Hoon Ahn. Clinical features and prognosis of hepatocellular carcinoma with respect to pre‐S deletion and basal core promoter mutations of hepatitis B virus Genotype C2. Journal of Medical Virology 2011; 83(12) doi: 10.1002/jmv.22238
|
| 199 |
Metin Cetin, Gorkem Odabas, Leon R. Douglas, Patrick J. Duriez, Pelin Balcik-Ercin, Irem Yalim-Camci, Abdulkadir Emre Sayan, Tamer Yagci. ROR1 Expression and Its Functional Significance in Hepatocellular Carcinoma Cells. Cells 2019; 8(3) doi: 10.3390/cells8030210
|
| 200 |
Jia-Horng Kao. Hepatitis B vaccination and prevention of hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 2015; 29(6) doi: 10.1016/j.bpg.2015.09.011
|
| 201 |
Angela Risch, Narek Sarkisyan, David Scherf, Hanna Jacobsson, Wolfgang Hagmann, Christoph Plass. Epigenetic Epidemiology. 2012; doi: 10.1007/978-94-007-2495-2_13
|
| 202 |
Christian Steinberg, Suzanne Boudreau, Felix Leveille, Marc Lamothe, Patrick Chagnon, Isabelle Boulais. Advanced Hepatocellular Carcinoma with Subtotal Occlusion of the Inferior Vena Cava and a Right Atrial Mass. Case Reports in Vascular Medicine 2013; 2013 doi: 10.1155/2013/489373
|
| 203 |
Jin Lee, Kye-Taek Lim. Apoptotic activity of ethanol extract from Styrax Japonica Siebold et al Zuccarini in HepG2 cells. Journal of Ethnopharmacology 2010; 131(1) doi: 10.1016/j.jep.2010.06.026
|
| 204 |
Saira Rafaqat, Iqra Noshair, Momina Shahid, Sadaf Bibi, Ramsha Hafeez, Hafsa Hamid. Correlation between prognostic markers and clinical parameters in hepatocellular carcinoma: Pathophysiological aspects to therapeutic targets. World Journal of Gastrointestinal Oncology 2025; 17(5): 106278 doi: 10.4251/wjgo.v17.i5.106278
|
| 205 |
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
|
| 206 |
QING SHAO, PENGFEI REN, YANG LI, BO PENG, LIPING DAI, NINGJING LEI, WU YAO, GANG ZHAO, LINGGEN LI, JIANYING ZHANG. Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma. International Journal of Oncology 2012; 41(3) doi: 10.3892/ijo.2012.1515
|
| 207 |
Jian Jun Hu, Chong Hui Li, Hong Dong Wang, Wen Li Xu, Ai Qun Zhang, Jia Hong Dong. Portal vein clamping alone confers protection against hepatic ischemia–reperfusion injury via preserving hepatocyte function in cirrhotic rats. Journal of Surgical Research 2015; 194(1) doi: 10.1016/j.jss.2014.10.003
|
| 208 |
Mangesh Chikhale, Pampa Ch Toi, Neelaiah Siddaraju, Ramesh Ananthakrishnan. The strength of cytomorphology and efficacy of immuno‐cytochemistry in distinguishing hepatocellular carcinoma from its mimics on fine‐needle aspiration cytology. Diagnostic Cytopathology 2021; 49(7) doi: 10.1002/dc.24759
|
| 209 |
. 2022; doi: 10.70675/20983419z3198z40cczbda7z7db398966080
|
| 210 |
Shane A. Wells. Quantification of Hepatic Fat and Iron with Magnetic Resonance Imaging. Magnetic Resonance Imaging Clinics of North America 2014; 22(3) doi: 10.1016/j.mric.2014.04.010
|
| 211 |
Soungmun Kim, Seogsong Jeong, Sun Jae Park, Jooyoung Chang, Seulggie Choi, Yoosun Cho, Joseph C. Ahn, Gyeongsil Lee, Joung Sik Son, Sang Min Park. Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study. Journal of Clinical Medicine 2022; 11(10) doi: 10.3390/jcm11102865
|
| 212 |
|
| 213 |
Julie Konfortion, Victoria H. Coupland, Hemant M. Kocher, William Allum, Melanie J. Grocock, Ruth H. Jack. Time and deprivation trends in incidence of primary liver cancer subtypes in England. Journal of Evaluation in Clinical Practice 2014; 20(4) doi: 10.1111/jep.12188
|
| 214 |
Hongwei He, Qing Zhang, Qiyun Gu, Hui Yang, Caibin Yue. CircGNAO1 strengthens its host gene GNAO1 expression for suppression of hepatocarcinogenesis. Heliyon 2024; 10(12) doi: 10.1016/j.heliyon.2024.e32848
|
| 215 |
Kai Lei, Yichun Lei, Zeyao Wang, Zhixin Ye, Jiawei Liu, Wenhao Chen, Caihong Zhou, Jinmei Tan, Shuxian Chen, Yifan Zhang, Jiehui Tan. Integrative multi-omics and Mendelian randomization analysis reveal SPP1+ tumor-associated macrophage-driven prognostic signature for hepatocellular carcinoma. Frontiers in Molecular Biosciences 2025; 12 doi: 10.3389/fmolb.2025.1594610
|
| 216 |
. 2011; doi: 10.70675/31da6ed7z7ed9z484az90c5z4c8433be6dc0
|
| 217 |
ZHANJUN GUO, HUA YANG, CUIJU WANG, SHUFENG LIU. Mitochondrial DNA haplogroup M is associated with late onset of hepatocellular carcinoma. Experimental and Therapeutic Medicine 2012; 3(3) doi: 10.3892/etm.2011.434
|
| 218 |
Ya-Sian Chang, Ya-Ting Lee, Ju-Chen Yen, Yuli C. Chang, Li-Li Lin, Wen-Ling Chan, Wei-Chiao Chang, Shyr-Yi Lin, Jan-Gowth Chang. Long Noncoding RNA NTT Context-Dependently Regulates MYB by Interacting With Activated Complex in Hepatocellular Carcinoma Cells. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.592045
|
| 219 |
Niamat Ullah Khan, Asma Sadiq, Jadoon Khan, Nosheen Basharat, Zulfiqar Ul Hassan, Ijaz Ali, Tawaf Ali Shah, Mohammed Bourhia, Yousef A. Bin Jardan, Gezahign Fentahun Wondmie. Molecular characterization of plasma virome of hepatocellular carcinoma (HCC) patients. AMB Express 2024; 14(1) doi: 10.1186/s13568-024-01696-2
|
| 220 |
Takashi Ohtani, Tomokazu Ishida, Kumi Ozaki, Kouki Takahashi, Masato Shimada, Eiji Kidoya. Usefulness of Electron Density Calculated from Dual Energy CT in Differential Diagnosis between Hepatocellular Carcinoma and Hepatic Hemangioma. Japanese Journal of Radiological Technology 2023; 79(12) doi: 10.6009/jjrt.2023-1387
|
| 221 |
L. Monfardini, P. Della Vigna, G. Bonomo, F. Orsi, M. Tullii, D. Disalvatore, S. Monfardini. Interventional oncology in the elderly: Complications and early response in liver and kidney malignancies. Journal of Geriatric Oncology 2013; 4(1) doi: 10.1016/j.jgo.2012.09.001
|
| 222 |
KAI SONG, JUNHUA WU, CHUNPING JIANG. Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review). Oncology Reports 2013; 29(1) doi: 10.3892/or.2012.2082
|
| 223 |
Danielle M. Tholey, Joseph Ahn. Impact of Hepatitis C Virus Infection on Hepatocellular Carcinoma. Gastroenterology Clinics of North America 2015; 44(4) doi: 10.1016/j.gtc.2015.07.005
|
| 224 |
Jin U. Kim, I. Jane Cox, Simon D. Taylor-Robinson. The Quest for Relevant Hepatocellular Carcinoma Biomarkers. Cellular and Molecular Gastroenterology and Hepatology 2017; 4(2) doi: 10.1016/j.jcmgh.2017.06.003
|
| 225 |
Masnoon Saiyed, Joshua Byrnes, Tushar Srivastava, Paul Scuffham, Martin Downes. Cost-Effectiveness of Lenvatinib Compared with Sorafenib for the First-Line Treatment of Advanced Hepatocellular Carcinoma in Australia. Clinical Drug Investigation 2020; 40(12) doi: 10.1007/s40261-020-00983-7
|
| 226 |
Daniel M. Girardi, Jana Priscila M. Pacífico, Fernanda P. L. Guedes de Amorim, Gustavo dos Santos Fernandes, Marcela C. Teixeira, Allan A. L. Pereira. Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment Perspectives. Pharmaceuticals 2020; 14(1) doi: 10.3390/ph14010028
|
| 227 |
Yun Hee Kang, Na Young Ji, Chung Il Lee, Hee Gu Lee, Jae Wha Kim, Young IL Yeom, Dae Ghon Kim, Seung Kew Yoon, Jong Wan Kim, Pil Je Park, Eun Young Song. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma. Amino Acids 2011; 40(3) doi: 10.1007/s00726-010-0729-6
|
| 228 |
Rui Cao, Hongguang Liu , Zhen Cheng. Radiolabeled Peptide Probes for Liver Cancer Imaging. Current Medicinal Chemistry 2020; 27(41) doi: 10.2174/0929867327666200320153837
|
| 229 |
Howard Lim, Ravi Ramjeesingh, Dave Liu, Vincent C Tam, Jennifer J Knox, Paul B Card, Brandon M Meyers. Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review. JNCI: Journal of the National Cancer Institute 2021; 113(2) doi: 10.1093/jnci/djaa119
|
| 230 |
Janine Graham, Helen L. Reeves. Non‐Alcoholic Fatty Liver Disease. 2013; doi: 10.1002/9781118556153.ch17
|
| 231 |
Hsiang-Chun Lai, Hung-Jen Lin, Ying-Hsiu Shih, Jen-Wei Chou, Kuan-Wen Lin, Long-Bin Jeng, Sheng-Teng Huang. LipoCol Forte capsules reduce the risk of liver cancer: A propensity score-matched, nationwide, population-based cohort study. World Journal of Gastrointestinal Oncology 2023; 15(5): 828-842 doi: 10.4251/wjgo.v15.i5.828
|
| 232 |
Alexia Karen Cotte, Vanessa Cottet, Virginie Aires, Thomas Mouillot, Maud Rizk, Sandrine Vinault, Christine Binquet, Jean-Paul Pais de Barros, Patrick Hillon, Dominique Delmas. Phospholipid profiles and hepatocellular carcinoma risk and prognosis in cirrhotic patients. Oncotarget 2019; 10(22) doi: 10.18632/oncotarget.26738
|
| 233 |
James O'Connell, Siobhan Rooney. Screening for hepatocellular carcinoma in chronic liver disease: a systematic review and meta-analysis of randomized controlled trials comparing screening methodologies. Journal of Global Health Reports 2020; 4 doi: 10.29392/001c.12924
|
| 234 |
K. V. Menon, A. R. Hakeem, N. D Heaton. Review article: liver transplantation for hepatocellular carcinoma – a critical appraisal of the current worldwide listing criteria. Alimentary Pharmacology & Therapeutics 2014; 40(8) doi: 10.1111/apt.12922
|
| 235 |
Philipp Heumann, Andreas Albert, Karsten Gülow, Deniz Tümen, Martina Müller, Arne Kandulski. Insights in Molecular Therapies for Hepatocellular Carcinoma. Cancers 2024; 16(10) doi: 10.3390/cancers16101831
|
| 236 |
Grace Chappell, Igor P. Pogribny, Kathryn Z. Guyton, Ivan Rusyn. Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review. Mutation Research/Reviews in Mutation Research 2016; 768 doi: 10.1016/j.mrrev.2016.03.004
|
| 237 |
R. N. Komarov, R. B. Alikhanov, S. V. Chernyavskiy, P. P. Kim, A. G. Yavorovskiy, R. S. Goloshchapov-aksenov. Left hemihepatectomy with thrombectomy from inferior vena cava and right atrium under cardiopulmonary bypass in patient with hepatocellular carcinoma. Khirurgiya. Zhurnal im. N.I. Pirogova 2017; (11) doi: 10.17116/hirurgia20171182-84
|
| 238 |
John M. Page, Stephen A. Harrison. NASH and HCC. Clinics in Liver Disease 2009; 13(4) doi: 10.1016/j.cld.2009.07.007
|
| 239 |
Xiaofei Li, Wenjun Yang, Lianqing Lou, Yongxin Chen, Shuang Wu, Guoqiang Ding. microRNA: A Promising Diagnostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Digestive Diseases and Sciences 2014; 59(6) doi: 10.1007/s10620-013-3006-1
|
| 240 |
Ruptured HCC Presenting as Acute Abdomen in a Non-cirrhotic Patient: a Diagnostic and Management Challenge. Indian Journal of Surgery 2021; 83(4) doi: 10.1007/s12262-020-02485-4
|
| 241 |
Gorantla Sri Charitha, Nyshadham S.N. Chaitanya, Aramati Bindu Madhava Reddy. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; doi: 10.1016/B978-0-323-98807-0.00017-X
|
| 242 |
Changqing Zhao, Mindie H. Nguyen. Hepatocellular Carcinoma Screening and Surveillance. Journal of Clinical Gastroenterology 2016; 50(2) doi: 10.1097/MCG.0000000000000446
|
| 243 |
Priscila Henriques da Silva, Matheus Menezes Gomes, Carla Adriana Loureiro de Matos, Ivonete Sandra de Souza e Silva, Adriano Miziara Gonzalez, Ulysses S. Torres, Gloria Maria Martinez Salazar, Giuseppe D'Ippolito. HCC Detection on Surveillance US. Journal of Ultrasound in Medicine 2021; 40(11) doi: 10.1002/jum.15637
|
| 244 |
Leigh Ann White, Joseph Menzin, Jonathan R. Korn, Mark Friedman, Kathy Lang, Saurabh Ray. Medical Care Costs and Survival Associated With Hepatocellular Carcinoma Among the Elderly. Clinical Gastroenterology and Hepatology 2012; 10(5) doi: 10.1016/j.cgh.2011.12.031
|
| 245 |
Ali Soleimani, Jafar Hassanzadeh, Ali Ghanbari Motlagh, Hamidreza Tabatabaee, Elham Partovipour, Sareh Keshavarzi, Mohammad Hossein. Spatial Analysis of Common Gastrointestinal Tract Cancers in Counties of Iran. Asian Pacific Journal of Cancer Prevention 2015; 16(9) doi: 10.7314/APJCP.2015.16.9.4025
|
| 246 |
P. A. Shuper, M. Neuman, F. Kanteres, D. Baliunas, N. Joharchi, J. Rehm. Causal Considerations on Alcohol and HIV/AIDS -- A Systematic Review. Alcohol and Alcoholism 2010; 45(2) doi: 10.1093/alcalc/agp091
|
| 247 |
Magdalena Śmiech, Paweł Leszczyński, Christopher Wardell, Piotr Poznański, Mariusz Pierzchała, Hiroaki Taniguchi. Oncogenic Mutation BRAF V600E Changes Phenotypic Behavior of THLE-2 Liver Cells through Alteration of Gene Expression. International Journal of Molecular Sciences 2022; 23(3) doi: 10.3390/ijms23031548
|
| 248 |
Hui Liu, Songhao Jia, Kun Guo, Rongkuan Li. INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma. Bioscience Reports 2022; 42(7) doi: 10.1042/BSR20221082
|
| 249 |
Xiangkun Wang, Xin Zhou, Junqi Liu, Zhengqian Liu, Linbo Zhang, Yizhen Gong, Jianlu Huang, Long Yu, Qiaoqi Wang, Chengkun Yang, Xiwen Liao, Tingdong Yu, Chuangye Han, Guangzhi Zhu, Xinping Ye, Tao Peng. Genome‑wide investigation of the clinical implications and molecular mechanism of long noncoding RNA LINC00668 and protein‑coding genes in hepatocellular carcinoma. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4858
|
| 250 |
Zeinab Fazeli, Mohamad Amin Pourhoseingholi, Mohsen Vahedi, Mohammad Reza Zali. Burden of Hepatocellular Carcinoma in Asia. Asian Pacific Journal of Cancer Prevention 2012; 13(12) doi: 10.7314/APJCP.2012.13.12.5955
|
| 251 |
Kuo Chao Yew, Quan Rui Tan, Phei Ching Lim, Wei Yang Low, Chong Yew Lee. Assessing the impact of direct-acting antivirals on hepatitis C complications: a systematic review and meta-analysis. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(3) doi: 10.1007/s00210-023-02716-x
|
| 252 |
Mahmoud Abu-Amara, Orlando Cerocchi, Gurtej Malhi, Suraj Sharma, Colina Yim, Hemant Shah, David K Wong, Harry L A Janssen, Jordan J Feld. The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection. Gut 2016; 65(8) doi: 10.1136/gutjnl-2014-309099
|
| 253 |
C.-C. Chiu, J.-J. Wang, Y.-S. Chen, J.-J. Chen, T.-C. Tsai, C.-C. Lai, D.-P. Sun, H.-Y. Shi. Trends and predictors of outcomes after surgery for hepatocellular carcinoma: A nationwide population-based study in Taiwan. European Journal of Surgical Oncology (EJSO) 2015; 41(9) doi: 10.1016/j.ejso.2015.04.023
|
| 254 |
Yunyun Yang, Ju Zhou, Ying Yang, Zhi Chen, Xiaodong Zheng. Systematic review and meta-analysis: dairy consumption and hepatocellular carcinoma risk. Journal of Public Health 2017; 25(6) doi: 10.1007/s10389-017-0806-3
|
| 255 |
RESEARCH OF ADSORPTION AFLATOXINS BY TECHNICAL LIGNIN. World Science 2021; (10(71)) doi: 10.31435/rsglobal_ws/30112021/7703
|
| 256 |
Dong Sun, Jinghui Lu, Chunxiao Hu, Qiangbo Zhang, Xiangdong Wang, Zongli Zhang, Sanyuan Hu. Prognostic role of miR‑760 in hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9546
|
| 257 |
Zhen Yang, Ruoyu Miao, Guangbing Li, Yan Wu, Simon Robson, Xiaobo Yang, Yi Zhao, Haitao Zhao, Yang Zhong. Identification of Recurrence Related microRNAs in Hepatocellular Carcinoma after Surgical Resection. International Journal of Molecular Sciences 2013; 14(1) doi: 10.3390/ijms14011105
|
| 258 |
Marco D'Anzeo, Luca Faloppi, Mario Scartozzi, Riccardo Giampieri, Maristella Bianconi, Michela Del Prete, Nicola Silvestris, Stefano Cascinu. The role of Micro-RNAs in Hepatocellular Carcinoma: From Molecular Biology to Treatment. Molecules 2014; 19(5) doi: 10.3390/molecules19056393
|
| 259 |
Xiaobin Feng, Ruocai Xu, Xilin Du, Kefeng Dou, Xiao Qin, Jun Xu, Weidong Jia, Zhiming Wang, Hongzhi Zhao, Shufa Yang, Chenyang Guo, Tianqi Liu, Kuansheng Ma. Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0–B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study. American Journal of Gastroenterology 2014; 109(12) doi: 10.1038/ajg.2014.343
|
| 260 |
Zi-Cheng Jiang, Xian-Mei Tang, Ying-Ren Zhao, Lei Zheng. A functional variant at miR-34a binding site in toll-like receptor 4 gene alters susceptibility to hepatocellular carcinoma in a Chinese Han population. Tumor Biology 2014; 35(12) doi: 10.1007/s13277-014-2547-z
|
| 261 |
Hassan Yazdanpanah, Samira Eslamizad. Biological Toxins and Bioterrorism. Toxinology 2015; doi: 10.1007/978-94-007-5869-8_11
|
| 262 |
Sohail Hussain, Abdulmajeed M. Jali, Saeed Alshahrani, Khairat H. M. Khairat, Rahimullah Siddiqui, Mohammad Intakhab Alam, Raisuddin Ali, Manal Mohammed, Andleeb Khan, Hamad Al Shahi, Ali Hanbashi, Marwa Qadri, Mohammad Ashafaq. Hepatoprotective and Antioxidant Effects of Nanopiperine against Cypermethrin via Mitigation of Oxidative Stress, Inflammations and Gene Expression Using qRT-PCR. International Journal of Molecular Sciences 2023; 24(20) doi: 10.3390/ijms242015361
|
| 263 |
Xiaodong Wen, Lacy Reynolds, Rohit S. Mulik, Soo Young Kim, Tim Van Treuren, Liem H. Nguyen, Hao Zhu, Ian R. Corbin. Hepatic Arterial Infusion of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Selectively Disrupts Redox Balance in Hepatoma Cells and Reduces Growth of Orthotopic Liver Tumors in Rats. Gastroenterology 2016; 150(2) doi: 10.1053/j.gastro.2015.10.008
|
| 264 |
Obaid Afzal, Pavan Goud, Kavita Goyal, Ali Altharawi, Mubarak A. Alamri, Manal A. Alossaimi, Abdulmalik S.A. Altamimi, Surya Nath Pandey. Multi-omics biomarker detection in Diethylnitrosamine (DENA) induced hepatocellular carcinoma. Clinica Chimica Acta 2026; 587 doi: 10.1016/j.cca.2026.120937
|
| 265 |
The Stem Cell Niche during Ageing. Advances in Stem Cells and their Niches 2020; 4 doi: 10.1016/bs.asn.2020.07.002
|
| 266 |
Maha L. Zamzam. Epidemiologic and Clinicopathologic Features of Advanced Hepatocellular Carcinoma. Journal of Cancer Therapy 2019; 10(06) doi: 10.4236/jct.2019.106034
|
| 267 |
Binfeng Wang, Miaomiao Ma, Xiaojun Guo, Yan Yan, Lang Li. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk. Medicine 2021; 100(41) doi: 10.1097/MD.0000000000027527
|
| 268 |
Elisa Bustaffa, Liliana Cori, Adele Manzella, Daniela Nuvolone, Fabrizio Minichilli, Fabrizio Bianchi, Francesca Gorini. The health of communities living in proximity of geothermal plants generating heat and electricity: A review. Science of The Total Environment 2020; 706 doi: 10.1016/j.scitotenv.2019.135998
|
| 269 |
Alan P. Venook, Christos Papandreou, Junji Furuse, Laura Ladrón de Guevara. The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective. The Oncologist 2010; 15(S4) doi: 10.1634/theoncologist.2010-S4-05
|
| 270 |
Jarrod Bailey. An Examination of Chimpanzee Use in Human Cancer Research. Alternatives to Laboratory Animals 2009; 37(4) doi: 10.1177/026119290903700410
|
| 271 |
CM McCarthy, M McCarthy, K O’Donoghue. Recurrent hepatocellular carcinoma in pregnancy: A case report and literature review. Obstetric Medicine 2019; 12(4) doi: 10.1177/1753495X18784074
|
| 272 |
Wei Sang, Wei Zhang, Wenli Cui, Xinxia Li, Gulinar Abulajiang, Qiaoxin Li. Arginase-1 is a more sensitive marker than HepPar-1 and AFP in differential diagnosis of hepatocellular carcinoma from nonhepatocellular carcinoma. Tumor Biology 2015; 36(5) doi: 10.1007/s13277-014-3030-6
|
| 273 |
Teera Kangkhetkron, Chudchawal Juntarawijit. Factors Influencing Practice of Pesticide Use and Acute Health Symptoms among Farmers in Nakhon Sawan, Thailand. International Journal of Environmental Research and Public Health 2021; 18(16) doi: 10.3390/ijerph18168803
|
| 274 |
Qian Zhou, Vivian WY Lui, Winnie Yeo. Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma. Future Oncology 2011; 7(10) doi: 10.2217/fon.11.95
|
| 275 |
T W Chew, X J Liu, L Liu, J M Spitsbergen, Z Gong, B C Low. Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models. Oncogene 2014; 33(21) doi: 10.1038/onc.2013.240
|
| 276 |
. 2011; doi: 10.70675/d0cee40bzccc7z4246z9e6dz30a9ceb07c18
|
| 277 |
Evelyn Lamy, Anke Hertrampf, Corinna Herz, Julia Schüler, Miriam Erlacher, Daniela Bertele, Adekunle Bakare, Meike Wagner, Timo Weiland, Ulrich Lauer, Oliver Drognitz, Roman Huber, Sascha Rohn, Torsten Giesemann, Volker Mersch-Sundermann, Manlio Vinciguerra. Preclinical Evaluation of 4-Methylthiobutyl Isothiocyanate on Liver Cancer and Cancer Stem Cells with Different p53 Status. PLoS ONE 2013; 8(8) doi: 10.1371/journal.pone.0070846
|
| 278 |
Yexiong Tan, Peiyuan Yin, Liang Tang, Wenbin Xing, Qiang Huang, Dan Cao, Xinjie Zhao, Wenzhao Wang, Xin Lu, Zhiliang Xu, Hongyang Wang, Guowang Xu. Metabolomics Study of Stepwise Hepatocarcinogenesis From the Model Rats to Patients: Potential Biomarkers Effective for Small Hepatocellular Carcinoma Diagnosis. Molecular & Cellular Proteomics 2012; 11(2) doi: 10.1074/mcp.M111.010694
|
| 279 |
Linda L. Wong, Christopher J. Kim, Sandi A. Kwee, Brenda Y. Hernandez. Alpha-fetoprotein testing for hepatocellular carcinoma may not be helpful in nonalcoholic steatohepatitis. Open Journal of Gastroenterology 2013; 3(01) doi: 10.4236/ojgas.2013.31008
|
| 280 |
Yoshitaka Takuma, Iwadou Shota, Hirokazu Miyatake, Shuji Uematsu, Ryouichi Okamoto, Yasuyuki Araki, Hiroyuki Takabatake, Youichi Morimoto, Hiroshi Yamamoto. Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma. Internal Medicine 2018; 57(4) doi: 10.2169/internalmedicine.9064-17
|
| 281 |
Lisha Mou, Zuhui Pu, Yongxiang Luo, Ryan Quan, Yunhu So, Hui Jiang. Construction of a lipid metabolism-related risk model for hepatocellular carcinoma by single cell and machine learning analysis. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1036562
|
| 282 |
Tran Duc Dung, Cecilia Hsuan Day, Truong Viet Binh, Chih-Hsueh Lin, Hsi-Hsien Hsu, Cheng-Chuan Su, Yueh-Min Lin, Fuu-Jen Tsai, Wei-Wen Kuo, Li-Mien Chen, Chih-Yang Huang. PP2A mediates diosmin p53 activation to block HA22T cell proliferation and tumor growth in xenografted nude mice through PI3K–Akt–MDM2 signaling suppression. Food and Chemical Toxicology 2012; 50(5) doi: 10.1016/j.fct.2012.01.021
|
| 283 |
Gary C. Kanel, Jacob Korula. Atlas of Liver Pathology. 2011; doi: 10.1016/B978-1-4377-0765-6.10010-2
|
| 284 |
Nisar Ahmed, Areej Riaz, Bisma Bashir Ahmed, Ramin Noorzai. Comment on “Role of ALBI Grade as a Predictive Factor for Long‐Term Mortality in Patients With Hepatocellular Carcinoma (HCC) Undergoing Trans‐Arterial Chemoembolization (TACE)”. Journal of Gastroenterology and Hepatology 2026; 41(3) doi: 10.1111/jgh.70243
|
| 285 |
Afsaneh Bazgir, Mehdi Agha Gholizadeh, Ayyoob Khosravi, Nader Mansour Samaei. The X-ray Repair Cross-Complementing Group 1 Arg399Gln Genetic Polymorphism and Risk of Hepatocellular Carcinoma in an Iranian Population. Middle East Journal of Digestive Diseases 2018; 10(1) doi: 10.15171/mejdd.2017.89
|
| 286 |
Yoshiaki Mizuguchi, Toshihiro Takizawa, Hiroshi Yoshida, Eiji Uchida. Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review. Hepatology Research 2016; 46(5) doi: 10.1111/hepr.12606
|
| 287 |
David J Hughes, Talita Duarte-Salles, Sandra Hybsier, Antonia Trichopoulou, Magdalena Stepien, Krasimira Aleksandrova, Kim Overvad, Anne Tjønneland, Anja Olsen, Aurélie Affret, Guy Fagherazzi, Marie-Christine Boutron-Ruault, Verena Katzke, Rudolf Kaaks, Heiner Boeing, Christina Bamia, Pagona Lagiou, Eleni Peppa, Domenico Palli, Vittorio Krogh, Salvatore Panico, Rosario Tumino, Carlotta Sacerdote, Hendrik Bastiaan Bueno-de-Mesquita, Petra H Peeters, Dagrun Engeset, Elisabete Weiderpass, Cristina Lasheras, Antonio Agudo, Maria-José Sánchez, Carmen Navarro, Eva Ardanaz, Miren Dorronsoro, Oskar Hemmingsson, Nicholas J Wareham, Kay-Tee Khaw, Kathryn E Bradbury, Amanda J Cross, Marc Gunter, Elio Riboli, Isabelle Romieu, Lutz Schomburg, Mazda Jenab. Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort. The American Journal of Clinical Nutrition 2016; 104(2) doi: 10.3945/ajcn.116.131672
|
| 288 |
Danielle M Tholey, Ben Hornung, Charles K Enestvedt, Yiyi Chen, Willscott S Naugler, Khashayar Farsad, Nima Nabavizadeh, Barry Schlansky, Joseph Ahn, Janice H Jou. Close observation versus upfront treatment in hepatocellular carcinoma: are the exception points worth the risk?. BMJ Open Gastroenterology 2017; 4(1) doi: 10.1136/bmjgast-2017-000157
|
| 289 |
Silvia Ribback, Verena Sailer, Enrico Böhning, Julia Günther, Jaqueline Merz, Frauke Steinmüller, Kirsten Utpatel, Antonio Cigliano, Kristin Peters, Maria Pilo, Matthias Evert, Diego Calvisi, Frank Dombrowski. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models. International Journal of Molecular Sciences 2016; 17(10) doi: 10.3390/ijms17101618
|
| 290 |
Yoon-Chul Kim. Advanced Methods in Dynamic Contrast Enhanced Arterial Phase Imaging of the Liver. Investigative Magnetic Resonance Imaging 2019; 23(1) doi: 10.13104/imri.2019.23.1.1
|
| 291 |
Nada Assi, Marc J Gunter, Duncan C Thomas, Michael Leitzmann, Magdalena Stepien, Véronique Chajès, Thierry Philip, Paolo Vineis, Christina Bamia, Marie-Christine Boutron-Ruault, Torkjel M Sandanger, Amaia Molinuevo, Hendriek Boshuizen, Anneli Sundkvist, Tilman Kühn, Ruth Travis, Kim Overvad, Elio Riboli, Augustin Scalbert, Mazda Jenab, Vivian Viallon, Pietro Ferrari. Metabolic signature of healthy lifestyle and its relation with risk of hepatocellular carcinoma in a large European cohort. The American Journal of Clinical Nutrition 2018; 108(1) doi: 10.1093/ajcn/nqy074
|
| 292 |
Alexey Surov, Maciej Pech, Jazan Omari, Frank Fischbach, Robert Damm, Katharina Fischbach, Maciej Powerski, Borna Relja, Andreas Wienke. Diffusion-Weighted Imaging Reflects Tumor Grading and Microvascular Invasion in Hepatocellular Carcinoma. Liver Cancer 2021; 10(1) doi: 10.1159/000511384
|
| 293 |
Xixia Huang, Hong Wang, Wenhong Zhang, Erli Gu. Verification of hepatitis B–related hepatocellular carcinoma predictive models to evaluate the risk of HCC in patients with liver cirrhosis under antiviral treatment. European Journal of Gastroenterology & Hepatology 2022; 34(5) doi: 10.1097/MEG.0000000000002302
|
| 294 |
Shohei Okazaki, Kei Shibuya, Shintaro Shiba, Tomoyuki Takura, Tatsuya Ohno. Cost-Effectiveness Comparison of Carbon-Ion Radiation Therapy and Transarterial Chemoembolization for Hepatocellular Carcinoma. Advances in Radiation Oncology 2024; 9(4) doi: 10.1016/j.adro.2024.101441
|
| 295 |
Qian Wu, Pei Wang, Qihang Peng, Zhongcui Kang, Yiting Deng, Jiayi Li, Ying Chen, Jin Li, Feng Ge. Adhesion G Protein-Coupled Receptor G2 Promotes Hepatocellular Carcinoma Progression and Serves as a Neutrophil-Related Prognostic Biomarker. International Journal of Molecular Sciences 2023; 24(23) doi: 10.3390/ijms242316986
|
| 296 |
V. Sivaramakrishnan, S. Niranjali Devaraj. Morin regulates the expression of NF-κB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chemico-Biological Interactions 2009; 180(3) doi: 10.1016/j.cbi.2009.02.004
|
| 297 |
Massimiliano Berretta, Elisa Garlassi, Bruno Cacopardo, Alessandro Cappellani, Giovanni Guaraldi, Stefania Cocchi, Paolo De Paoli, Arben Lleshi, Immacolata Izzi, Augusta Torresin, Pietro Di Gangi, Antonello Pietrangelo, Mariachiara Ferrari, Alessandra Bearz, Salvatore Berretta, Guglielmo Nasti, Fabrizio Di Benedetto, Luca Balestreri, Umberto Tirelli, Paolo Ventura. Hepatocellular Carcinoma in HIV-Infected Patients: Check Early, Treat Hard. The Oncologist 2011; 16(9) doi: 10.1634/theoncologist.2010-0400
|
| 298 |
Masako Shomura, Tatehiro Kagawa, Koichi Shiraishi, Shunji Hirose, Yoshitaka Arase, Jun Koizumi, Tetsuya Mine. Skin toxicity predicts efficacy to sorafenib in patients with advanced hepatocellular carcinoma. World Journal of Hepatology 2014; 6(9): 670-676 doi: 10.4254/wjh.v6.i9.670
|
| 299 |
Nobuyuki Shimizu, Hiroshi Shiraishi, Toshikatsu Hanada. Zebrafish as a Useful Model System for Human Liver Disease. Cells 2023; 12(18) doi: 10.3390/cells12182246
|
| 300 |
Wenyi Liu, Lingqiao Wang, Chuanfen Zheng, Lebin Liu, Jia Wang, Daibo Li, Yao Tan, Xilong Zhao, Lixiong He, Weiqun Shu. Microcystin-LR increases genotoxicity induced by aflatoxin B1 through oxidative stress and DNA base excision repair genes in human hepatic cell lines. Environmental Pollution 2018; 233 doi: 10.1016/j.envpol.2017.10.067
|
| 301 |
Lisha Mou, Chenyang Jia, Zijing Wu, Boyang Xin, Carmen Alicia Liang Zhen, Bailiang Wang, Yong Ni, Zuhui Pu. Clinical and Prognostic Value of PPIA, SQSTM1, and CCL20 in Hepatocellular Carcinoma Patients by Single-Cell Transcriptome Analysis. Cells 2022; 11(19) doi: 10.3390/cells11193078
|
| 302 |
Concetta Panebianco, Chiara Saracino, Valerio Pazienza. Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression. Tumor Biology 2014; 35(8) doi: 10.1007/s13277-014-2075-x
|
| 303 |
Wang Zhifang. Analysis of Risk Factors for Development of Hepatocellular Carcinoma in Chronic HBV - Infected Liver Cirrhosis Patients: A Meta-Analysis. International Journal of Immunotherapy and Cancer Research 2017; doi: 10.17352/2455-8591.000017
|
| 304 |
Naoki Watanabe, Koji Takai, Kenji Imai, Masahito Shimizu, Takafumi Naiki, Masahito Nagaki, Hisataka Moriwaki. Increased levels of serum leptin are a risk factor for the recurrence of stage I/II hepatocellular carcinoma after curative treatment. Journal of Clinical Biochemistry and Nutrition 2011; 49(3) doi: 10.3164/jcbn.10-149
|
| 305 |
Chunhua Bei, Chao Tan, Xiaonian Zhu, Zhigang Wang, Shengkui Tan. Association Between Polymorphisms in CMTM Family Genes and Hepatocellular Carcinoma in Guangxi of China. DNA and Cell Biology 2018; 37(8) doi: 10.1089/dna.2018.4274
|
| 306 |
Amina A Abd El Fattah, Magdy M Youssef, Mohamed Abdel-Wahab, Mona S Gouida, Hoda M El-Emshaty. Assessment of osteopontin and vascular endothelial growth factor for diagnostic performance of Egyptians hepatocellular carcinoma. Laboratory Medicine 2026; 57(1) doi: 10.1093/labmed/lmaf075
|
| 307 |
Shuai Xue, Fengqin Lu, Chunhui Sun, Jingjing Zhao, Honghua Zhen, Xin Li. LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02176-8
|
| 308 |
Jinyan Zhao, Yunpeng Zhao, Hao Wang, Xing Gu, Jun Ji, Chunfang Gao. Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: A cross-sectional study. Nutrition Journal 2011; 10(1) doi: 10.1186/1475-2891-10-49
|
| 309 |
Shital S. Panchal, Somsuvra B. Ghatak, Abhishek B. Jha, Raoul Onattu. Reduction of liver tumerogenic effect of N-nitrosodiethylamine by treatment with ɣ-oryzanol in Balb/C mice. Environmental Toxicology and Pharmacology 2017; 56 doi: 10.1016/j.etap.2017.08.006
|
| 310 |
Abdullah Esmail, Yazan Hamadneh, Bayan Khasawneh, Maryam Al-Rawi, Ebtesam Al-Najjar, Vikram Dhillon, Ahmad Alhaj, Yaser Rayyan, Maen Abdelrahim. Atezolizumab Plus Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma: An Institutional Experience. Biomedicines 2025; 13(12) doi: 10.3390/biomedicines13122844
|
| 311 |
Koushik Sarker , Avijit Ghosh , Abhijit Saha, Suvasish Mishra, Subrata Sen. Pharmacophore Based Design of Probable FGFR-1 Inhibitors from the 3D
Crystal Structure of Infigratinib - A Drug Used in the Treatment of
Cholangiocarcinomas. Letters in Drug Design & Discovery 2022; 19(4) doi: 10.2174/1570180818666211007113720
|
| 312 |
Kai Bai, Yi Cao, Chao Huang, Jianwei Chen, Xiaojin Zhang, Yi Jiang. Association of Histone Methyltransferase G9a and Overall Survival After Liver Resection of Patients With Hepatocellular Carcinoma With a Median Observation of 40 Months. Medicine 2016; 95(2) doi: 10.1097/MD.0000000000002493
|
| 313 |
Lutz Schomburg, David J. Hughes. The missing link? The potential role of selenium in the development of liver cancer and significance for the general population. Expert Review of Gastroenterology & Hepatology 2017; 11(8) doi: 10.1080/17474124.2017.1320219
|
| 314 |
Gang Huang, Eric C. H. Lai, Wan Yee Lau, Wei-ping Zhou, Feng Shen, Ze-ya Pan, Si-yuan Fu, Meng-chao Wu. Posthepatectomy HBV Reactivation in Hepatitis B–Related Hepatocellular Carcinoma Influences Postoperative Survival in Patients With Preoperative Low HBV-DNA Levels. Annals of Surgery 2013; 257(3) doi: 10.1097/SLA.0b013e318262b218
|
| 315 |
Ehab Abdel-Atti. HCC Burden in Egypt. Gastroenterology & Hepatology : Open Access 2015; 2(3) doi: 10.15406/ghoa.2015.02.00045
|
| 316 |
Magdalena Stepien, Veronika Fedirko, Talita Duarte-Salles, Pietro Ferrari, Heinz Freisling, Elisabeth Trepo, Antonia Trichopoulou, Christina Bamia, Elisabete Weiderpass, Anja Olsen, Anne Tjønneland, Kim Overvad, Marie-Christine Boutron-Ruault, Guy Fagherazzi, Antoine Racine, Tilman Kühn, Rudolf Kaaks, Krasimira Aleksandrova, Heiner Boeing, Pagona Lagiou, Vassiliki Benetou, Dimitrios Trichopoulos, Domenico Palli, Sara Grioni, Rosario Tumino, Alessio Naccarati, Salvatore Panico, H. Bas. Bueno-de-Mesquita, Petra H. Peeters, Eiliv Lund, J. Ramón Quirós, Osmel Companioni Nápoles, María-José Sánchez, Miren Dorronsoro, José María Huerta, Eva Ardanaz, Bodil Ohlsson, Klas Sjöberg, Mårten Werner, Hanna Nystrom, Kay-Tee Khaw, Timothy J. Key, Marc Gunter, Amanda Cross, Elio Riboli, Isabelle Romieu, Mazda Jenab. Prospective association of liver function biomarkers with development of hepatobiliary cancers. Cancer Epidemiology 2016; 40 doi: 10.1016/j.canep.2016.01.002
|
| 317 |
Fuqing Gao, Yun Li, Haiqing Zhao, Yannei Liang, Zhe Liu. Sub-chronic, low dose co-exposure to Aflatoxin B1 and Microcystin-LR in C57BL/6 mice significantly alters the cytokine response in serum and liver. CyTA - Journal of Food 2022; 20(1) doi: 10.1080/19476337.2022.2130436
|
| 318 |
Santu Kumar Samanta, Shubhadeep Adak, Tridib Tripathy. Adsorption studies of toxic organic pesticides from aqueous medium by sodium alginate‐cl‐poly (allyl amine‐co‐acrylic acid)/copper oxide nanocomposite hydrogel: Isotherms, kinetics, and thermodynamics. Polymer Engineering & Science 2024; 64(4) doi: 10.1002/pen.26648
|
| 319 |
Shahid A. Khan, Mireille B. Toledano, Abigail Zabron, Mehtan Ahmed, Simon D. Taylor‐Robinson. Clinical Dilemmas in Primary Liver Cancer. 2011; doi: 10.1002/9781119962205.ch4
|
| 320 |
Benyuan Deng, Fei Liu, Yonggang Wei, Limei Luo, Xi Chen, Lvnan Yan, Bo Li. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of hepatocellular carcinoma in a Chinese population. Tumor Biology 2013; 34(1) doi: 10.1007/s13277-012-0550-9
|
| 321 |
Mona Abu El Makarem. An Overview of Biomarkers for the Diagnosis of Hepatocellular Carcinoma. Hepatitis Monthly 2012; 12(10 HCC) doi: 10.5812/hepatmon.6122
|
| 322 |
Junyu Huo, Xinyi Fan, Bingxin Qi, Peng Sun. A Five-Gene Signature Associated With DNA Damage Repair Molecular Subtype Predict Overall Survival for Hepatocellular Carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.771819
|
| 323 |
DONG KEUN SEOK, SAE YOON KEE, SOON YOUNG KO, JUNG HWA LEE, HYE YOUNG KIM, IN SUN KIM, HEE YEON SEO. Leukemia cutis in a patient with acute monocytic leukemia diagnosed simultaneously with hepatocellular carcinoma: A case study. Oncology Letters 2013; 6(5) doi: 10.3892/ol.2013.1580
|
| 324 |
Defne Bayik, Adam J. Lauko, Gustavo A. Roversi, Emily Serbinowski, Lou-Anne Acevedo-Moreno, Christopher Lanigan, Mushfig Orujov, Alice Lo, Tyler J. Alban, Adam Kim, Daniel J. Silver, Laura E. Nagy, J. Mark Brown, Daniela S. Allende, Federico N. Aucejo, Justin D. Lathia. Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75881-1
|
| 325 |
Aditi Varshney, Jiban J. Panda, Avishek K. Singh, Nitin Yadav, Chhagan Bihari, Subhrajit Biswas, Shiv K. Sarin, Virander S. Chauhan. Targeted delivery of microRNA‐199a‐3p using self‐assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice. Hepatology 2018; 67(4) doi: 10.1002/hep.29643
|
| 326 |
Qian Shen, Shanshan Shi, Haoxue Wang, Shanshan Zhang, Shifan Qin, Xia Sheng, Jiang Chang, Xuehong Zhang, Xiang Cheng, Rong Zhong. Serum 25‐hydroxyvitamin D, vitamin D‐related variants, and risk of chronic liver disease. International Journal of Cancer 2025; 157(9) doi: 10.1002/ijc.35522
|
| 327 |
. 2021; doi: 10.70675/0bb9fa70z5648z44eazab59zc2a4236991a3
|
| 328 |
Xiao-Fei Li, Hua-Bin He, Yan-Shuang Zhu, Jin-Ke He, Wei-Wei Ye, Yong-Xin Chen, Lian-Qing Lou. Association Between the c.3751G>A Genetic Variant of MDR1 and Hepatocellular Carcinoma Risk in a Chinese Han Population. Asian Pacific Journal of Cancer Prevention 2013; 14(9) doi: 10.7314/APJCP.2013.14.9.5361
|
| 329 |
Xiao-Lian Zhang, Yu Lu, Shi Yang, Qi-Liu Peng, Jian Wang, Li Xie, Yan Deng, Yu He, Tai-Jie Li, Xue Qin, Shan Li. An Updated Meta-analysis Between the Association of XRCC1 Arg399Gln Polymorphism and Hepatocellular Carcinoma Risk. Asian Pacific Journal of Cancer Prevention 2014; 15(7) doi: 10.7314/APJCP.2014.15.7.3273
|
| 330 |
Kulthida Y. Kopolrat, Sunisa Chaiklieng, Paiboon Sithithaworn, Pornnapa Suggaravetsiri, Vichai Pruktharathikul, Kannika Trinnawoottipong. Associations between pesticide exposure and hepatobiliary disease among agricultural workers in the Northeastern region of Thailand: a cross-sectional study. Journal of Occupational Medicine and Toxicology 2025; 20(1) doi: 10.1186/s12995-025-00470-9
|
| 331 |
Vito Longo, Antonio Gnoni, Andrea Casadei Gardini, Salvatore Pisconti, Antonella Licchetta, Mario Scartozzi, Riccardo Memeo, Vincenzo Ostilio Palmieri, Giuseppe Aprile, Daniele Santini, Patrizia Nardulli, Nicola Silvestris, Oronzo Brunetti. Immunotherapeutic approaches for hepatocellular carcinoma. Oncotarget 2017; 8(20) doi: 10.18632/oncotarget.15406
|
| 332 |
Miny Samuel, Pierce K-H Chow, Edwin Chan Shih-Yen, David Machin, Khee-Chee Soo. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2009; 2010(1) doi: 10.1002/14651858.CD001199.pub2
|
| 333 |
Xiaoyan Liang, Ge Xu, Qing Gao, Xiaohong Tao. LKB1 expression reverses the tumorigenicity of L02 cells. Oncology Reports 2016; 36(2) doi: 10.3892/or.2016.4900
|
| 334 |
Allisson B. Justino, Rodrigo M. Florentino, Andressa França, Antonio C. M. L. Filho, Rodrigo R. Franco, André L. Saraiva, Matheus C. Fonseca, Maria F. Leite, Foued Salmen Espindola, Walid Elfalleh. Alkaloid and acetogenin-rich fraction from Annona crassiflora fruit peel inhibits proliferation and migration of human liver cancer HepG2 cells. PLOS ONE 2021; 16(7) doi: 10.1371/journal.pone.0250394
|
| 335 |
Xi Wang, Xuelong Zhang, Bing Qiu, Yinhua Tang, He Sun, Hongfei Ji, Yan Liu, Lijun Shi, Guang Song, Youlin Yang. MDM2 SNP309T>G polymorphism increases susceptibility to hepatitis B virus‐related hepatocellular carcinoma in a northeast Han Chinese population. Liver International 2012; 32(7) doi: 10.1111/j.1478-3231.2012.02787.x
|
| 336 |
Gregory C Connolly, Saman Safadjou, Randeep Kashyap, Rui Chen, Mark S Orloff, Aram F Hezel. Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinoma. BMC Gastroenterology 2013; 13(1) doi: 10.1186/1471-230X-13-9
|
| 337 |
Mi Na Kim, Jung Oh Kim, Seung Min Lee, Hana Park, Ju Ho Lee, Kyu Sung Rim, Seong Gyu Hwang, Nam Keun Kim, Seung Up Kim. Variation in the Dicer and RAN Genes Are Associated with Survival in Patients with Hepatocellular Carcinoma. PLOS ONE 2016; 11(9) doi: 10.1371/journal.pone.0162279
|
| 338 |
Stella Sun, Ronnie T. P. Poon, Nikki P. Lee, Chun Yeung, K. L. Chan, Irene O. L. Ng, Philip J. R. Day, John M. Luk. Proteomics of Hepatocellular Carcinoma: Serum Vimentin As a Surrogate Marker for Small Tumors (≤2 cm). Journal of Proteome Research 2010; 9(4) doi: 10.1021/pr901085z
|
| 339 |
Junping Ao, Jiao Meng, Lei Zhu, Huizhen Nie, Chenchen Yang, Jinjun Li, Jianren Gu, Qiushi Lin, Weiwen Long, Xiaoqun Dong, Chao Li. Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion. Molecular Oncology 2012; 6(5) doi: 10.1016/j.molonc.2012.06.005
|
| 340 |
XIAOLEI LI, ZHAOXU YANG, WENJIE SONG, LIANG ZHOU, QINGJUN LI, KAISHAN TAO, JINGSHI ZHOU, XING WANG, ZHIGANG ZHENG, NAN YOU, KEFENG DOU, HAIMIN LI. Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)-2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway. International Journal of Oncology 2013; 43(3) doi: 10.3892/ijo.2013.1992
|
| 341 |
Mohammad Nurul Amin, Md. Saddam Hussain, Md. Shahid Sarwar, Md. Mizanur Rahman Moghal, Abhijit Das, Mohammad Zahid Hossain, Jakir Ahmed Chowdhury, Md. Shalahuddin Millat, Mohammad Safiqul Islam. How the association between obesity and inflammation may lead to insulin resistance and cancer. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(2) doi: 10.1016/j.dsx.2019.01.041
|
| 342 |
Maíra Luciana Marconcini, Leonardo Fayad, Maria Beatriz Cacese Shiozawa, Esther Buzaglo Dantas-Correa, Leonardo de Lucca Schiavon, Janaína Luz Narciso-Schiavon. Autoantibody profile in individuals with chronic hepatitis C. Revista da Sociedade Brasileira de Medicina Tropical 2013; 46(2) doi: 10.1590/0037-8682-0039-2013
|
| 343 |
Jiao-Jiao Hu, Wei Song, Shao-Dan Zhang, Xiao-Hui Shen, Xue-Mei Qiu, Hua-Zhang Wu, Pi-Hai Gong, Sen Lu, Zhu-Jiang Zhao, Ming-Liang He, Hong Fan. HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling. Scientific Reports 2016; 6(1) doi: 10.1038/srep23521
|
| 344 |
. 2019; doi: 10.70675/3d5a49c5z2759z457cz98fdz241c81d1347c
|
| 345 |
Dalvinder S Mandair, Roberta E Rossi, Marinos Pericleous, Tara Whyand, Martyn Caplin. The impact of diet and nutrition in the prevention and progression of hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2014; 8(4) doi: 10.1586/17474124.2014.894879
|
| 346 |
Xiaoqian Huang, Li Zhou, Zhiyuan Gong.
Liver Tumor Models in Transgenic Zebrafish: An Alternative
In Vivo
Approach to Study Hepatocarcinogenes
. Future Oncology 2012; 8(1) doi: 10.2217/fon.11.137
|
| 347 |
Shengyu Huang, Yong Xia, Zhengqing Lei, Qifei Zou, Jun Li, Tian Yang, Kui Wang, Zhenlin Yan, Xuying Wan, Feng Shen. Antiviral Therapy Inhibits Viral Reactivation and Improves Survival after Repeat Hepatectomy for Hepatitis B Virus-Related Recurrent Hepatocellular Carcinoma. Journal of the American College of Surgeons 2017; 224(3) doi: 10.1016/j.jamcollsurg.2016.11.009
|
| 348 |
Yoshitaka Takuma, Hiroyuki Takabatake, Youichi Morimoto, Nobuyuki Toshikuni, Takahisa Kayahara, Yasuhiro Makino, Hiroshi Yamamoto. Comparison of Combined Transcatheter Arterial Chemoembolization and Radiofrequency Ablation with Surgical Resection by Using Propensity Score Matching in Patients with Hepatocellular Carcinoma within Milan Criteria. Radiology 2013; 269(3) doi: 10.1148/radiol.13130387
|
| 349 |
Jan Tore Gran, Ragnar Gunnarsson, Nils-Jørgen Mørk. En mann med erytrodermi, muskelsvakhet og vekttap. Tidsskrift for Den norske legeforening 2009; 129(21) doi: 10.4045/tidsskr.09.0184
|
| 350 |
Sabrina Schlesinger, Krasimira Aleksandrova, Tobias Pischon, Veronika Fedirko, Mazda Jenab, Elisabeth Trepo, Paolo Boffetta, Christina C. Dahm, Kim Overvad, Anne Tjønneland, Jytte Halkjær, Guy Fagherazzi, Marie‐Christine Boutron‐Ruault, Franck Carbonnel, Rudolf Kaaks, Annekatrin Lukanova, Heiner Boeing, Antonia Trichopoulou, Christina Bamia, Pagona Lagiou, Domenico Palli, Sara Grioni, Salvatore Panico, Rosario Tumino, Paolo Vineis, Bueno‐de‐Mesquita HB, Saskia van den Berg, Petra H.M. Peeters, Tonje Braaten, Elisabete Weiderpass, J. Ramón Quirós, Noémie Travier, María‐José Sánchez, Carmen Navarro, Aurelio Barricarte, Miren Dorronsoro, Björn Lindkvist, Sara Regner, Mårten Werner, Malin Sund, Kay‐Tee Khaw, Nicholas Wareham, Ruth C. Travis, Teresa Norat, Petra A. Wark, Elio Riboli, Ute Nöthlings. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. International Journal of Cancer 2013; 132(3) doi: 10.1002/ijc.27645
|
| 351 |
Duminda Suraweera, Peter Konyn, Thomas Vu, Sammy Saab. Clinical Epidemiology of Chronic Liver Diseases. 2019; doi: 10.1007/978-3-319-94355-8_15
|
| 352 |
. 2019; doi: 10.70675/69fcf365zf2daz456czb4d4z3a379bab1f88
|
| 353 |
Manuela Cabiati, Melania Gaggini, Paolo De Simone, Silvia Del Ry. Evaluation of Apelin/APJ system expression in hepatocellular carcinoma as a function of clinical severity. Clinical and Experimental Medicine 2021; 21(2) doi: 10.1007/s10238-020-00672-x
|
| 354 |
P. C Yadala, A H M Viswanath Swamy. CHEMO PREVENTIVE EFFECT OF PIPERINE IN N-NITROSODIETHYLAMINEINDUCED AND PHENOBARBITAL PROMOTED EXPERIMENTAL RAT HEPATOCELLULAR CARCINOMA. INDIAN DRUGS 2017; 54(05) doi: 10.53879/id.54.05.10813
|
| 355 |
Erin C. Connolly, Koenraad Van Doorslaer, Leslie E. Rogler, Charles E. Rogler. Overexpression of miR-21 Promotes an In vitro Metastatic Phenotype by Targeting the Tumor Suppressor RHOB. Molecular Cancer Research 2010; 8(5) doi: 10.1158/1541-7786.MCR-09-0465
|
| 356 |
Linhe Wang, Xiangchao Ling, Caihui Zhu, Zhiheng Zhang, Ziming Wang, Shanzhou Huang, Yunhua Tang, Shujiao He, Zhiyong Guo, Xiaoshun He. Upregulated Seizure-Related 6 Homolog-Like 2 Is a Prognostic Predictor of Hepatocellular Carcinoma. Disease Markers 2020; 2020 doi: 10.1155/2020/7318703
|
| 357 |
Dan Liu, Daniel Y. T. Fong, Albert C. Y. Chan, Ronnie T. P. Poon, Pek-Lan Khong. Hepatocellular Carcinoma: Surveillance CT Schedule after Hepatectomy Based on Risk Stratification. Radiology 2015; 274(1) doi: 10.1148/radiol.14132343
|
| 358 |
Tyler Gorham, Elisabeth Dowling Root, Yuanyuan Jia, C.K. Shum, Jiyoung Lee. Relationship between cyanobacterial bloom impacted drinking water sources and hepatocellular carcinoma incidence rates. Harmful Algae 2020; 95 doi: 10.1016/j.hal.2020.101801
|
| 359 |
Colleen S. Curran, Elad Sharon. PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma. Seminars in Oncology 2017; 44(6) doi: 10.1053/j.seminoncol.2017.12.001
|
| 360 |
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato. Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors. Biomedicines 2023; 11(10) doi: 10.3390/biomedicines11102761
|
| 361 |
Mahitha Lampimukhi, Tabarak Qassim, Rakshaya Venu, Nivedita Pakhala, Suchita Mylavarapu, Tharindu Perera, Beeran S Sathar, Arun Nair. A Review of Incidence and Related Risk Factors in the Development of Hepatocellular Carcinoma. Cureus 2023; doi: 10.7759/cureus.49429
|
| 362 |
Yan Xu, Li Liu, Jibin Liu, Yixin Zhang, Jian Zhu, Jianguo Chen, Sheng Liu, Zheng Liu, Haibin Shi, Hongbing Shen, Zhibin Hu. A potentially functional polymorphism in the promoter region of miR‐34b/c is associated with an increased risk for primary hepatocellular carcinoma. International Journal of Cancer 2011; 128(2) doi: 10.1002/ijc.25342
|
| 363 |
A.D. Jones, J.C. Wilton. Can intra-operative fluorescence play a significant role in hepatobiliary surgery?. European Journal of Surgical Oncology 2017; 43(9) doi: 10.1016/j.ejso.2017.02.015
|
| 364 |
Sung Hwan Cho, Kyoungjune Pak, Dae Cheon Jeong, Myoung‐Eun Han, Sae‐Ock Oh, Yun Hak Kim. The AP2M1 gene expression is a promising biomarker for predicting survival of patients with hepatocellular carcinoma. Journal of Cellular Biochemistry 2019; 120(3) doi: 10.1002/jcb.27699
|
| 365 |
Mehdi Sabzichi, Omolbanin Oladpour, Jamal Mohammadian, Mohsen Rashidi, Mahla Hosseinzadeh, Alireza Mardomi, Bahman Ramezani, Marjan Ghorbani, Fatemeh Ramezani. RETRACTED ARTICLE: Zoledronic acid-loaded lipidic nanoparticles enhance apoptosis and attenuate invasiveness by inhibiting epithelial to mesenchymal transition (EMT) in HepG2 cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology 2021; 394(12) doi: 10.1007/s00210-021-02164-5
|
| 366 |
Xuehong Chen, Yantao Han, Songmei Zhan, Chunbo Wang, Shouguo Chen.
Tegillarca granosa Extract Haishengsu Induces Apoptosis in Human Hepatocellular Carcinoma Cell Line BEL-7402 Via Fas-Signaling Pathways. Cell Biochemistry and Biophysics 2015; 71(2) doi: 10.1007/s12013-014-0271-3
|
| 367 |
Andrew Bang, Laura A. Dawson. Radiotherapy for HCC: Ready for prime time?. JHEP Reports 2019; 1(2) doi: 10.1016/j.jhepr.2019.05.004
|
| 368 |
Youwu Hao, Yang Zhang, Hongfei Ni, Jufang Gao, Yun Yang, Wenping Xu, Liming Tao. Evaluation of the cytotoxic effects of glyphosate herbicides in human liver, lung, and nerve. Journal of Environmental Science and Health, Part B 2019; 54(9) doi: 10.1080/03601234.2019.1633215
|
| 369 |
Li Weng, Juan Du, Qinghui Zhou, Binbin Cheng, Jun Li, Denghai Zhang, Changquan Ling. Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection. Molecular Cancer 2012; 11(1) doi: 10.1186/1476-4598-11-39
|
| 370 |
Shao-Cheng Zhu, Yue-Hua Liu, Yi Wei, Lin-Lin Li, She-Wei Dou, Ting-Yi Sun, Da-Peng Shi. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging. World Journal of Gastroenterology 2018; 24(8): 929-940 doi: 10.3748/wjg.v24.i8.929
|
| 371 |
Kurt Sartorius, Leo Swadling, Ping An, Julia Makarova, Cheryl Winkler, Anil Chuturgoon, Anna Kramvis. The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways. Viruses 2020; 12(7) doi: 10.3390/v12070746
|
| 372 |
Yonghua Niu, Tairi Huang, Feng Lian, Fenghua Li. Contrast-enhanced ultrasonography for the diagnosis of small hepatocellular carcinoma: a meta-analysis and meta-regression analysis. Tumor Biology 2013; 34(6) doi: 10.1007/s13277-013-0948-z
|
| 373 |
E.J. Monroe, M.J. Kogut, C.R. Ingraham, S.W. Kwan, D.S. Hippe, S.A. Padia. Outcomes of emergent embolisation of ruptured hepatocellular carcinoma in a western population. Clinical Radiology 2015; 70(7) doi: 10.1016/j.crad.2015.03.007
|
| 374 |
Jinhwan Kim, Joho Yun, Kwanghyun Kim, Nah Ihm Kim, Hee Joon Kim, Jong-Hyun Lee.
Ex-Vivo Identification of Tumor From Parenchyma in Human Liver Using Electrochemical Impedance Spectroscopy on a Needle. IEEE Sensors Journal 2020; 20(23) doi: 10.1109/JSEN.2020.3008722
|
| 375 |
M. Eslam, T. Kawaguchi, J. A. Del Campo, M. Sata, M. Abo-Elneen Khattab, M. Romero-Gomez. Use of HOMA-IR in hepatitis C. Journal of Viral Hepatitis 2011; 18(10) doi: 10.1111/j.1365-2893.2011.01474.x
|
| 376 |
XIA YING, YUE ZHAO, JUN-LAN WANG, XIA ZHOU, JING ZHAO, CHEN-CHEN HE, XI-JING GUO, GUI-HUA JIN, LI-JUAN WANG, QING ZHU, SU-XIA HAN. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma. Oncology Reports 2014; 32(4) doi: 10.3892/or.2014.3367
|
| 377 |
Shrinivas Sharma, Lakshmi KS, V. Chitra, I. Aparna Lakshmi, M. Pharm. Anticarcinogenic Activity of Allylmercaptocaptopril Against Aflatoxin-B1 Induced Liver Carcinoma in Rats. Electronic Journal of General Medicine 2011; 8(1) doi: 10.29333/ejgm/82696
|
| 378 |
Su Pin Choo, Wan Ling Tan, Brian K. P. Goh, Wai Meng Tai, Andrew X. Zhu. Comparison of hepatocellular carcinoma in Eastern versus Western populations. Cancer 2016; 122(22) doi: 10.1002/cncr.30237
|
| 379 |
Gang Huang, Wan Yee Lau, Zhen-Guang Wang, Ze-Ya Pan, Sheng-Xian Yuan, Feng Shen, Wei-Ping Zhou, Meng-Chao Wu. Antiviral Therapy Improves Postoperative Survival in Patients With Hepatocellular Carcinoma. Annals of Surgery 2015; 261(1) doi: 10.1097/SLA.0000000000000858
|
| 380 |
|
| 381 |
Richard H. Hinton, Paul Grasso, Timothy C. Marrs. General, Applied and Systems Toxicology. 2009; doi: 10.1002/9780470744307.gat068
|
| 382 |
Ping Lu, Hefen Sun, Lixing Zhang, Helei Hou, Lin Zhang, Fangyu Zhao, Chao Ge, Ming Yao, Tingpu Wang, Jinjun Li. Isocorydine Targets the Drug-Resistant Cellular Side Population through PDCD4-Related Apoptosis in Hepatocellular Carcinoma. Molecular Medicine 2012; 18(7) doi: 10.2119/molmed.2012.00055
|
| 383 |
|
| 384 |
Hamza Tahir, Manisha Verma, Bakhtawer Siraj, Richard S. Kalman. Navigating Cirrhosis: Presentation, Outcomes, and Treatments in Adulthood and Beyond. Current Treatment Options in Gastroenterology 2024; 22(4) doi: 10.1007/s11938-024-00461-5
|
| 385 |
. 2023; doi: 10.70675/0d32d6d2z7f26z4069za536z07c505f8cff2
|
| 386 |
Janusz Kocjan, Mateusz Rydel, Mariusz Adamek. Hepatocellular Carcinoma (HCC) Metastasis to the Diaphragm Muscle: A Systematic Review and Meta-Analysis of Case Reports. Cancers 2024; 16(17) doi: 10.3390/cancers16173076
|
| 387 |
Michele Di Martino, Luca Saba, Sandro Bosco, Massimo Rossi, Kirchin A. Miles, Rossella Di Miscio, Concetta Valentina Lombardo, Elisabetta Tamponi, Mario Piga, Carlo Catalano. Hepatocellular carcinoma (HCC) in non-cirrhotic liver: clinical, radiological and pathological findings. European Radiology 2014; 24(7) doi: 10.1007/s00330-014-3173-2
|
| 388 |
Brad Q. Starley, Christopher J. Calcagno, Stephen A. Harrison. Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection. Hepatology 2010; 51(5) doi: 10.1002/hep.23594
|
| 389 |
Renumathy Dhanasekaran, Roniel Cabrera. Primary Liver Cancer. 2012; doi: 10.1007/978-1-61779-863-4_14
|
| 390 |
Jing Sun, Chan Zhang, Yong-Li Bao, Yin Wu, Zhong-Liang Chen, Chun-Lei Yu, Yan-Xin Huang, Ying Sun, Li-Hua Zheng, Xue Wang, Yu-Xin Li. Parthenolide-Induced Apoptosis, Autophagy and Suppression of Proliferation in HepG2 Cells. Asian Pacific Journal of Cancer Prevention 2014; 15(12) doi: 10.7314/APJCP.2014.15.12.4897
|
| 391 |
Randy Chung, Sahil Mittal. Managing Gastrointestinal Complications of Diabetes. 2017; doi: 10.1007/978-3-319-48662-8_6
|
| 392 |
Qian-Fei Cui, Chong Liu, Xue-Man Dong, Zhao-Qian Liu. Exploring the biological functions and disease implications of OSGINs: A journey from discovery to clinical relevance. Biochemical Pharmacology 2025; 237 doi: 10.1016/j.bcp.2025.116921
|
| 393 |
Ben Ariff, Claire R Lloyd, Sameer Khan, Mohamed Shariff, Andrew V Thillainayagam, Devinder S Bansi, Shahid A Khan, Simon D Taylor-Robinson, Adrian KP Lim. Imaging of liver cancer. World Journal of Gastroenterology 2009; 15(11): 1289-1300 doi: 10.3748/wjg.15.1289
|
| 394 |
Laura E. Martínez-Gómez, Norberto C. Chávez-Tapia, Ana I. Burguete-García, Nancy Aguilar-Olivos, Vicente Madrid-Marina, Margarita Román-Bahena, Citlalli Orbe-Orihuela, Uribe Misael, Nahum Méndez-Sánchez. IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population. Annals of Hepatology 2012; 11(6) doi: 10.1016/S1665-2681(19)31413-9
|
| 395 |
WEI LIN, JINYAN ZHAO, ZHIYUN CAO, QUNCHUAN ZHUANG, LIANGPU ZHENG, QIAOYAN CAI, DAXIN CHEN, LILI WANG, ZHENFENG HONG, JUN PENG. Livistona chinensis seed suppresses hepatocellular carcinoma growth through promotion of mitochondrial-dependent apoptosis. Oncology Reports 2013; 29(5) doi: 10.3892/or.2013.2319
|
| 396 |
Utz Settmacher, Silke Schüle, Ahmed Zidan, Hubert Scheuerlein, Falk Rauchfuss. Epidemiological Pattern of Hepatitis B and Hepatitis C as Etiological Agents for Hepatocellular Carcinoma in Iran and Worldwide. Hepatitis Monthly 2012; 12(10) doi: 10.5812/hepatmon.6894
|
| 397 |
Su Youn Nam. Obesity-Related Digestive Diseases and Their Pathophysiology. Gut and Liver 2017; 11(3) doi: 10.5009/gnl15557
|
| 398 |
Sheng‐Hsuan Lin, Yen‐Tsung Huang, Hwai‐I Yang. On identification of agonistic interaction: Hepatitis B and C interaction on hepatocellular carcinoma. Statistics in Medicine 2019; 38(13) doi: 10.1002/sim.8123
|
| 399 |
Jonggi Choi, Lewis R. Roberts. Statins and metformin for chemoprevention of hepatocellular carcinoma. Clinical Liver Disease 2016; 8(2) doi: 10.1002/cld.568
|
| 400 |
Georgi Kirovski, Axel P. Stevens, Barbara Czech, Katja Dettmer, Thomas S. Weiss, Peter Wild, Arndt Hartmann, Anja K. Bosserhoff, Peter J. Oefner, Claus Hellerbrand. Down-Regulation of Methylthioadenosine Phosphorylase (MTAP) Induces Progression of Hepatocellular Carcinoma via Accumulation of 5′-Deoxy-5′-Methylthioadenosine (MTA). The American Journal of Pathology 2011; 178(3) doi: 10.1016/j.ajpath.2010.11.059
|
| 401 |
Jack Leslie, Jill E. Hunter, Amy Collins, Amelia Rushton, Lauren G. Russell, Erik Ramon‐Gil, Maja Laszczewska, Misti McCain, Marco Y. W. Zaki, Amber Knox, Yixin Seow, Laura Sabater, Daniel Geh, Neil D. Perkins, Helen L. Reeves, Dina Tiniakos, Derek A. Mann, Fiona Oakley. c‐Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis. Hepatology 2023; 78(4) doi: 10.1002/hep.32781
|
| 402 |
Rory L. O’Donohoe, Richard G. Kavanagh, Alexis M. Cahalane, Diarmaid D. Houlihan, Jeffrey W. McCann, Edmund Ronan Ryan. C-arm cone-beam CT parenchymal blood volume imaging for transarterial chemoembolization of hepatocellular carcinoma: implications for treatment planning and response. European Radiology Experimental 2019; 3(1) doi: 10.1186/s41747-019-0099-0
|
| 403 |
Jian Gao. Association of MDR1 gene polymorphisms with the risk of hepatocellular carcinoma in the Chinese Han population. Brazilian Journal of Medical and Biological Research 2013; 46(3) doi: 10.1590/1414-431X20132774
|
| 404 |
Mohieldin M. Youssef , Mai F. Tolba, Noha N. Badawy, Andrew W. Liu, Eman El-Ahwany, Amani E. Khalifa, Suher Zada, Ashraf B. Abdel-Naim. Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells. Scientific Reports 2016; 6(1) doi: 10.1038/srep30717
|
| 405 |
Ying Xie, Shufeng Liu, Yufei Zhao, Lan Zhang, Yue Zhao, Binghui Liu, Zhanjun Guo, Isabelle A Chemin. Precore/Core Region Mutations in Hepatitis B Virus DNA Predict Postoperative Survival in Hepatocellular Carcinoma. PLOS ONE 2015; 10(7) doi: 10.1371/journal.pone.0133393
|
| 406 |
Sa’ed H. Zyoud. Global scientific trends on aflatoxin research during 1998–2017: a bibliometric and visualized study. Journal of Occupational Medicine and Toxicology 2019; 14(1) doi: 10.1186/s12995-019-0248-7
|
| 407 |
Mutlay Sayan, Nikhil Yegya-Raman, Stephanie H. Greco, Bin Gui, Andrew Zhang, Anupama Chundury, Miral S. Grandhi, Howard S. Hochster, Timothy J. Kennedy, Russell C. Langan, Usha Malhotra, Vinod K. Rustgi, Mihir M. Shah, Kristen R. Spencer, Darren R. Carpizo, John L. Nosher, Salma K. Jabbour. Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing Outcomes. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00345
|
| 408 |
Sulaiman S. Alhudaithi, Mohd Abul Kalam, Lama Binobaid, Raisuddin Ali, Mohammed M. Almutairi, Wajhul Qamar, Hessa Bin Hithlayn, Atheer Almutairi, Abdullah K. Alshememry. Sorafenib and Piperine co-loaded PLGA nanoparticles: Development, characterization, and anti-cancer activity against hepatocellular carcinoma cell line. Saudi Pharmaceutical Journal 2024; 32(5) doi: 10.1016/j.jsps.2024.102064
|
| 409 |
Zhanjun Guo, Chensi Wu, Xiaoling Wang, Cuiju Wang, Ruixing Zhang, Baoen Shan. A polymorphism at the miR‐502 binding site in the 3′‐untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome. International Journal of Cancer 2012; 131(6) doi: 10.1002/ijc.27352
|
| 410 |
Dhruvajyoti Roy, Elsie Oppermann, Thomas Vogl, Ibrahim Büdeyri, Dmitry Shapiro, Benjamin Struecker, Christian Rolfo, Nada Abedin, Vladimir Zharov, Andreas Schnitzbauer, Andreas Pascher, Wolf Bechstein, Markus Zimmermann, Mazen Juratli. The Prognostic Value of Circulating Stem Cells Expressing PD-L1 in Patients with Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2026; doi: 10.2147/JHC.S598753
|
| 411 |
Hideaki Miura, Takaaki Kawaguchi, Masakazu Takazoe, Shigehiro Kitamura, Haruki Yamada. Hepatocellular Carcinoma and Crohn's Disease: A Case Report and Review. Internal Medicine 2009; 48(10) doi: 10.2169/internalmedicine.48.1866
|
| 412 |
Hashem B. El-Serag. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma. Gastroenterology 2012; 142(6) doi: 10.1053/j.gastro.2011.12.061
|
| 413 |
Nisha Susan Thomas, Kiran George, Nalini Namasivayam. Molecular aspects and chemoprevention of dimethylaminoazobenzene‐induced hepatocarcinogenesis: A review. Hepatology Research 2016; 46(1) doi: 10.1111/hepr.12569
|
| 414 |
Tohru Niwa, Toshikazu Ushijima. Epigenetics and Cancer, Part B. Advances in Genetics 2010; 71 doi: 10.1016/B978-0-12-380864-6.00002-X
|
| 415 |
Pengfei Sun, Zhongchao Li, Bo Zhang. Characterization of disease-associated microbiota in hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2023; 19(4) doi: 10.4103/jcrt.jcrt_139_22
|
| 416 |
Yong-Qiang Ren, Ju-Qiang Han, Jian-Biao Cao, Shao-Xiang Li, Gong-Ren Fan. Association of MDR1 Gene Polymorphisms with Susceptibility to Hepatocellular Carcinoma in the Chinese Population. Asian Pacific Journal of Cancer Prevention 2012; 13(11) doi: 10.7314/APJCP.2012.13.11.5451
|
| 417 |
Anh Le Tuan Nguyen, Christopher Leigh Blizzard, Kwang Chien Yee, Andrew John Palmer, Barbara de Graaff. Survival of primary liver cancer for people from culturally and linguistically diverse backgrounds in Australia. Cancer Epidemiology 2022; 81 doi: 10.1016/j.canep.2022.102252
|
| 418 |
Monika Pazgan-Simon, Michał Kukla, Jolanta Zuwała-Jagiełło, Aleksandra Derra, Martyna Bator, Tomasz Menżyk, Andrzej Lekstan, Ewa Grzebyk, Krzysztof Simon, Matias A. Avila. Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC). PLOS ONE 2020; 15(1) doi: 10.1371/journal.pone.0227459
|
| 419 |
Haifei Yu, Wanyu Deng, Shuo Chen, Bo Qin, Yongxuan Yao, Changlin Zhou, Min Guo. Strongylocentrotus nudus egg polysaccharide (SEP) suppresses HBV replication via activation of TLR4-induced immune pathway. International Journal of Biological Macromolecules 2023; 245 doi: 10.1016/j.ijbiomac.2023.125539
|
| 420 |
Dafina Nikolova, Viktorija Chalovska, Magdalena Genadieva Ivanova, Emilija Nikolovska, Ance Volkanovska, Nikola Orovchanec, Slavica Kostadinova Kunovska, Gordana Petrushevska, Vesna Janevska. Immunohistochemical Expression of Epidermal Growth Factor Receptor in Hepatocellular Carcinoma. PRILOZI 2018; 39(2-3) doi: 10.2478/prilozi-2018-0038
|
| 421 |
Yang Liu, Aiqun Zhang, Yu Liu, Jiahong Dong. Association analysis between the c.1804C>A genetic polymorphism of XRCC1 gene and risk of hepatocellular carcinoma in Chinese population. Medical Oncology 2014; 31(3) doi: 10.1007/s12032-014-0854-2
|
| 422 |
Xin Wan, Ci Cheng, Zhe Lin, Runqiu Jiang, Wei Zhao, Xin Yan, Junwei Tang, Kun Yao, Beicheng Sun, Yun Chen. The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells. Oncotarget 2015; 6(11) doi: 10.18632/oncotarget.3558
|
| 423 |
Jiarui Li, Lei Xian, Ruipeng Zheng, Yue Wang, Xiaoqiang Wan, Ying Liu. Canthaxanthin shows anti-liver aging and anti-liver fibrosis effects by down-regulating inflammation and oxidative stress in vivo and in vitro. International Immunopharmacology 2022; 110 doi: 10.1016/j.intimp.2022.108942
|
| 424 |
Bibek Aryal, Munekazu Yamakuchi, Toshiaki Shimizu, Jun Kadono, Akira Furoi, Kentaro Gejima, Teruo Komokata, Teruto Hashiguchi, Yutaka Imoto. Deciphering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2018; 2018 doi: 10.1155/2018/9142672
|
| 425 |
Jieun Jang, Dae-Sung Yoo, Byung Chul Chun. Spatial epidemiologic analysis of the liver cancer and gallbladder cancer incidence and its determinants in South Korea. BMC Public Health 2021; 21(1) doi: 10.1186/s12889-021-12184-8
|
| 426 |
Cuiju Wang, Fengbin Zhang, Haiyan Fan, Li Peng, Ruixing Zhang, Shufeng Liu, Zhanjun Guo. Sequence polymorphisms of mitochondrial D-loop and hepatocellular carcinoma outcome. Biochemical and Biophysical Research Communications 2011; 406(3) doi: 10.1016/j.bbrc.2011.02.088
|
| 427 |
Sathish Kumar Mungamuri, Kotikalapudi Nagasuryaprasad. Epigenetics and Metabolomics. 2021; doi: 10.1016/B978-0-323-85652-2.00008-7
|
| 428 |
Michal Bitman, Radim Vrzal, Zdenek Dvorak, Petr Pavek. Valproate activates ERK signaling pathway in primary human hepatocytes. Biomedical Papers 2014; 158(1) doi: 10.5507/bp.2012.038
|
| 429 |
Da‐Ni Zhong, Qiu‐Yue Ning, Ji‐Zhou Wu, Ning Zang, Jian‐Lin Wu, Die‐Fei Hu, Shuang‐Yan Luo, Ai‐Chun Huang, Lan‐Lan Li, Guo‐Jian Li. Comparative proteomic profiles indicating genetic factors may involve in hepatocellular carcinoma familial aggregation. Cancer Science 2012; 103(10) doi: 10.1111/j.1349-7006.2012.02368.x
|
| 430 |
Minkyung Bae, Young-Ki Park, Ji-Young Lee. Food components with antifibrotic activity and implications in prevention of liver disease. The Journal of Nutritional Biochemistry 2018; 55 doi: 10.1016/j.jnutbio.2017.11.003
|
| 431 |
Hongliang Zang, Yuhui Li, Xue Zhang, Guomin Huang. <p>Circ_0000517 Contributes to Hepatocellular Carcinoma Progression by Upregulating TXNDC5 via Sponging miR-1296-5p</p>. Cancer Management and Research 2020; doi: 10.2147/CMAR.S244024
|
| 432 |
Markus Casper, Frank Grünhage, Frank Lammert. Cancer risk in chronic hepatitis B: Do genome-wide association studies hit the mark?. Hepatology 2011; 53(4) doi: 10.1002/hep.24241
|
| 433 |
Luca Falzone, Andrea Marconi, Carla Loreto, Sabrina Franco, Demetrios A. Spandidos, Massimo Libra. Occupational exposure to carcinogens: Benzene, pesticides and fibers. Molecular Medicine Reports 2016; 14(5) doi: 10.3892/mmr.2016.5791
|
| 434 |
Trang VoPham, Kimberly A. Bertrand, Jaime E. Hart, Francine Laden, Maria M. Brooks, Jian-Min Yuan, Evelyn O. Talbott, Darren Ruddell, Chung-Chou H. Chang, Joel L. Weissfeld. Pesticide exposure and liver cancer: a review. Cancer Causes & Control 2017; 28(3) doi: 10.1007/s10552-017-0854-6
|
| 435 |
Luca Quagliata, Manuel Schlageter, Cristina Quintavalle, Luigi Tornillo, Luigi Terracciano. Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA). Microarrays 2014; 3(2) doi: 10.3390/microarrays3020091
|
| 436 |
Jeong-Ju Yoo, Eun-Ae Jung, Sang Gyune Kim. Clinical Application of Liver Stiffness Measurement for Assessing the Risk of Hepatocellular Carcinoma. Journal of Liver Cancer 2019; 19(1) doi: 10.17998/jlc.19.1.12
|
| 437 |
Chia-Jui Yen, Masatoshi Kudo, Ho-Yeong Lim, Chih-Hung Hsu, Arndt Vogel, Giovanni Brandi, Rebecca Cheng, Ioana Simona Nitu, Paolo Abada, Yanzhi Hsu, Andrew X. Zhu, Yoon-Koo Kang. Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies. Liver Cancer 2020; 9(4) doi: 10.1159/000506946
|
| 438 |
Lohith Mysuru Shivanna, Asna Urooj. A Review on Dietary and Non-Dietary Risk Factors Associated with Gastrointestinal Cancer. Journal of Gastrointestinal Cancer 2016; 47(3) doi: 10.1007/s12029-016-9845-1
|
| 439 |
Nur Athirah Abd Rasid, Noor Azimah Muhammad. Unexplained Leg Swelling Leading to a Diagnosis of Hepatocellular Carcinoma: A Case Report. Cureus 2025; doi: 10.7759/cureus.84206
|
| 440 |
Fernando Gomes Romeiro, Luciana Yumi Odani Sigahi, Matheus Alvarez, Fabio da Silva Yamashiro, Fábio Cardoso de Carvalho, Leonardo Pelafsky, Talles Bazeia Lima, Letícia de Campos Franzoni, José Ricardo de Arruda Miranda, Giovanni Faria Silva. Sorafenib after Arterial Chemoembolization in Child-Pugh A and B Cirrhotic Patients with Intermediate Hepatocellular Carcinoma: A Retrospective Analysis. Journal of Cancer Therapy 2015; 6(03) doi: 10.4236/jct.2015.63031
|
| 441 |
Trang VoPham, Maria M. Brooks, Jian-Min Yuan, Evelyn O. Talbott, Darren Ruddell, Jaime E. Hart, Chung-Chou H. Chang, Joel L. Weissfeld. Pesticide exposure and hepatocellular carcinoma risk: A case-control study using a geographic information system (GIS) to link SEER-Medicare and California pesticide data. Environmental Research 2015; 143 doi: 10.1016/j.envres.2015.09.027
|
| 442 |
Toshihiro Furuta, Eriko Maeda, Hiroyuki Akai, Shouhei Hanaoka, Naoki Yoshioka, Masaaki Akahane, Takeyuki Watadani, Kuni Ohtomo. Hepatic Segments and Vasculature: Projecting CT Anatomy onto Angiograms. RadioGraphics 2009; 29(7) doi: 10.1148/rg.e37
|
| 443 |
M Dai, J Liu, D-E Chen, Y Rao, Z-J Tang, W-Z Ho, C-Y Dong. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice. Cancer Gene Therapy 2012; 19(2) doi: 10.1038/cgt.2011.65
|
| 444 |
Zhaleh Farokhizadeh, Sahar Dehbidi, Bita Geramizadeh, Ramin Yaghobi, Seyed Ali Malekhosseini, Mehrdad Behmanesh, Mohammad Hossein Sanati, Afsoon Afshari, Ali Moravej, Mohammad Hossein Karimi. Association of MicroRNA Polymorphisms With Hepatocellular Carcinoma in an Iranian Population. Annals of Laboratory Medicine 2019; 39(1) doi: 10.3343/alm.2019.39.1.58
|
| 445 |
Hyeong-Geug Kim, Seong-Soon Jang, Jin-Seok Lee, Hyo-Seon Kim, Chang-Gue Son. Panax ginseng Meyer prevents radiation-induced liver injury via modulation of oxidative stress and apoptosis. Journal of Ginseng Research 2017; 41(2) doi: 10.1016/j.jgr.2016.02.006
|
| 446 |
Yasunori Minami, Masatoshi Kudo. Biotargets of Cancer in Current Clinical Practice. 2012; doi: 10.1007/978-1-61779-615-9_10
|
| 447 |
Nghi B. Ha, Nghiem B. Ha, Aijaz Ahmed, Walid Ayoub, Tami J. Daugherty, Ellen T. Chang, Glen A. Lutchman, Gabriel Garcia, Allen D. Cooper, Emmet B. Keeffe, Mindie H. Nguyen. Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case–control study. Cancer Causes & Control 2012; 23(3) doi: 10.1007/s10552-012-9895-z
|
| 448 |
. 2012; doi: 10.70675/b5f3eb9dzef2az480fz93b6z6b19f8a3f305
|
| 449 |
Mary Qian YY, Rong Yuwei J, Peter Angus, Tony Schelleman, Lynne Johnson, Paul Gow. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital. Journal of Gastroenterology and Hepatology 2010; 25(5) doi: 10.1111/j.1440-1746.2009.06203.x
|
| 450 |
Zhan Gu, Xiuzhong Qi, Xiaofeng Zhai, Qingbo Lang, Jianying Lu, Changping Ma, Long Liu, Xiaoqiang Yue. Study on TCM Syndrome Differentiation of Primary Liver Cancer Based on the Analysis of Latent Structural Model. Evidence-Based Complementary and Alternative Medicine 2015; 2015 doi: 10.1155/2015/761565
|
| 451 |
Arun J. Sanyal, Seung Kew Yoon, Riccardo Lencioni. The Etiology of Hepatocellular Carcinoma and Consequences for Treatment. The Oncologist 2010; 15(S4) doi: 10.1634/theoncologist.2010-S4-14
|
| 452 |
Luciana Kikuchi, Aline L Chagas, Regiane SSM Alencar, Denise C Paranaguá-Vezozzo, Flair J Carrilho. Clinical and Epidemiological Aspects of Hepatocellular Carcinoma in Brazil. Antiviral Therapy 2013; 18(3_part_2) doi: 10.3851/IMP2602
|
| 453 |
Yun Hee Kang, Mi-Young Park, Do-Young Yoon, Seung Ro Han, Chung Il Lee, Na Young Ji, Pyung-Keun Myung, Hee Gu Lee, Jae Wha Kim, Young Il Yeom, Ye Jin Jang, Dong Kuk Ahn, Jong Wan Kim, Eun Young Song. Dysregulation of overexpressed IL-32α in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-κB and Bcl-2. Cancer Letters 2012; 318(2) doi: 10.1016/j.canlet.2011.12.023
|
| 454 |
Hiroyuki Akai, Izuru Matsuda, Shigeru Kiryu, Taku Tajima, Hidemasa Takao, Yasushi Watanabe, Hiroshi Imamura, Norihiro Kokudo, Masaaki Akahane, Kuni Ohtomo. Fate of hypointense lesions on Gd-EOB-DTPA-enhanced magnetic resonance imaging. European Journal of Radiology 2012; 81(11) doi: 10.1016/j.ejrad.2012.01.007
|
| 455 |
Areum Sohn, Hyunsoo Kim, Su Jong Yu, Jung-Hwan Yoon, Youngsoo Kim. A quantitative analytical method for PIVKA-II using multiple reaction monitoring-mass spectrometry for early diagnosis of hepatocellular carcinoma. Analytical and Bioanalytical Chemistry 2017; 409(11) doi: 10.1007/s00216-017-0227-8
|
| 456 |
Omar Karkoutly, Veerababu Nagati, Subhash C. Chauhan, Manish Tripathi. Computational Repurposing and Experimental Validation of YBX1 Inhibitors in Hepatocellular Carcinoma. Biomedicines 2026; 14(3) doi: 10.3390/biomedicines14030545
|
| 457 |
Omar Massoud, Michael Charlton. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. Clinics in Liver Disease 2018; 22(1) doi: 10.1016/j.cld.2017.08.014
|
| 458 |
Kongpop Duangchan, Nathachit Limjunyawong, Kamonlatth Rodponthukwaji, Teeranai Ittiudomrak, Mattika Thaweesuvannasak, Natsuda Kunwong, Chanatip Metheetrairut, Vorapan Sirivatanauksorn, Yongyut Sirivatanauksorn, Prawat Kositamongkol, Prawej Mahawithitwong, Chutwichai Tovikkai, Kytai T. Nguyen, Chatchawan Srisawat, Primana Punnakitikashem. Development of Small Interfering RNA Loaded Cationic Lipid Nanoparticles for the Treatment of Liver Cancer with Elevated α-Fetoprotein Expression. ACS Bio & Med Chem Au 2025; 5(1) doi: 10.1021/acsbiomedchemau.4c00061
|
| 459 |
Sene Waly Raphael, Zhang Yangde, Chen YuXiang. Hepatocellular Carcinoma: Focus on Different Aspects of Management. ISRN Oncology 2012; 2012 doi: 10.5402/2012/421673
|
| 460 |
Hans-Christian Pommergaard, Andreas Arendtsen Rostved, René Adam, Mauro Salizzoni, Miguel Angel Gómez Bravo, Daniel Cherqui, Paolo De Simone, Pauline Houssel-Debry, Vincenzo Mazzaferro, Olivier Soubrane, Juan Carlos García-Valdecasas, Joan Fabregat Prous, Antonio D. Pinna, John O’Grady, Vincent Karam, Christophe Duvoux, Lau Caspar Thygesen. Mortality after Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry. Liver Cancer 2020; 9(4) doi: 10.1159/000507397
|
| 461 |
Marcela Salomao, Helen Remotti, Roger Vaughan, Abby B. Siegel, Jay H. Lefkowitch, Roger Klein Moreira. The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis. Human Pathology 2012; 43(5) doi: 10.1016/j.humpath.2011.07.005
|
| 462 |
Adeyinka C. Adejumo, Tokunbo O. Ajayi, Oluwole M. Adegbala, Kelechi L. Adejumo, Samson Alliu, Akintunde M. Akinjero, Nnaemeka E. Onyeakusi, Ogooluwa Ojelabi, Terence N. Bukong. Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease. Liver International 2018; 38(8) doi: 10.1111/liv.13696
|
| 463 |
Yi‐Chuan Yu, Pedram Paragomi, Renwei Wang, Feiran Liang, Hung N. Luu, Jaideep Behari, Jian‐Min Yuan. High serum magnesium is associated with lower risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease. Cancer 2023; 129(15) doi: 10.1002/cncr.34799
|
| 464 |
Olusegun Sylvester Ojo. Liver cancer in Africa: untold aspects of an acknowledged scourge. The Lancet Gastroenterology & Hepatology 2017; 2(2) doi: 10.1016/S2468-1253(16)30179-0
|
| 465 |
Luca Quagliata, Mariacarla Andreozzi, Michal Kovac, Luigi Tornillo, Zuzanna Makowska, Francesca Moretti, Markus H. Heim, Karl Heinimann, Salvatore Piscuoglio, Luigi Maria Terracciano. SH2D4A is frequently downregulated in hepatocellular carcinoma and cirrhotic nodules. European Journal of Cancer 2014; 50(4) doi: 10.1016/j.ejca.2013.11.018
|
| 466 |
Derya Korkmaz, Petek Konya, Neşe Demirtürk. Investigation of the Characteristics of Crimean Congo Hemorrhagic Fever Cases Reported in Afyonkarahisar Province. Turkish Journal of Parasitology 2022; 46(3) doi: 10.4274/tpd.galenos.2022.14633
|
| 467 |
Kenji Imai, Koji Takai, Yoichi Nishigaki, Shogo Shimizu, Takafumi Naiki, Hideki Hayashi, Takahiro Uematsu, Junichi Sugihara, Eiichi Tomita, Masahito Shimizu, Masahito Nagaki, Hisataka Moriwaki. Insulin resistance raises the risk for recurrence of stage I hepatocellular carcinoma after curative radiofrequency ablation in hepatitis C virus‐positive patients: A prospective, case series study. Hepatology Research 2010; 40(4) doi: 10.1111/j.1872-034X.2009.00616.x
|
| 468 |
Fei Gao, Huifang Liang, Hanlin Lu, Junwen Wang, Meng Xia, Zhimei Yuan, Yu Yao, Tong Wang, Xiaolong Tan, Arian Laurence, Hua Xu, Jingjing Yu, Wei Xiao, Wei Chen, Ming Zhou, Xiuqing Zhang, Qian Chen, Xiaoping Chen. Global analysis of DNA methylation in hepatocellular carcinoma by a liquid hybridization capture-based bisulfite sequencing approach. Clinical Epigenetics 2015; 7(1) doi: 10.1186/s13148-015-0121-1
|
| 469 |
Hua Zhang, Yumei Cao, Yuru Chen, Guangxi Li, Hanshu Yu. Apatinib promotes apoptosis of the SMMC-7721 hepatocellular carcinoma cell line via the PI3K/Akt pathway. Oncology Letters 2018; doi: 10.3892/ol.2018.8031
|
| 470 |
Lawrence Wing Chi Chan, Sze Chuen Cesar Wong, William Chi Shing Cho, Mohan Huang, Fei Zhang, Man Lik Chui, Una Ngo Yin Lai, Tiffany Yuen Kwan Chan, Zoe Hoi Ching Cheung, Jerry Chun Yin Cheung, Kin Fu Tang, Man Long Tse, Hung Kit Wong, Hugo Man Fung Kwok, Xinping Shen, Sailong Zhang, Keith Wan Hang Chiu. Primary Tumor Radiomic Model for Identifying Extrahepatic Metastasis of Hepatocellular Carcinoma Based on Contrast Enhanced Computed Tomography. Diagnostics 2022; 13(1) doi: 10.3390/diagnostics13010102
|
| 471 |
ZHIKUN LIU, QI LING, JIANGUO WANG, HAIYANG XIE, XIAO XU, SHUSEN ZHENG. Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis. Oncology Letters 2013; 6(1) doi: 10.3892/ol.2013.1337
|
| 472 |
Antonio Giorgio, Antonella Di Sarno, Giorgio de Stefano, Nunzia Farella, Umberto Scognamiglio, Manuela de Stefano, Valentina Giorgio. Hepatocellular Carcinoma With Cirrhosis: Are Patients With Neoplastic Main Portal Vein Invasion Eligible for Percutaneous Radiofrequency Ablation of Both the Nodule and the Portal Venous Tumor Thrombus?. American Journal of Roentgenology 2009; 193(4) doi: 10.2214/AJR.08.2087
|
| 473 |
Stephanie Channual, Anokh Pahwa, David S. Lu, Steven S. Raman. Enhancements in hepatobiliary imaging: the spectrum of gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid usages in hepatobiliary magnetic resonance imaging. Abdominal Radiology 2016; 41(9) doi: 10.1007/s00261-016-0767-y
|
| 474 |
Yang Li, Yihong Cai, He Chen, Leijin Mao. Clinical significance and association of GSTP1 hypermethylation with hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2018; 14(Suppl 2) doi: 10.4103/0973-1482.181179
|
| 475 |
Shantel Olivares, Richard M. Green, Anne S. Henkel, Rajesh Mohanraj. Endoplasmic Reticulum Stress Activates the Hepatic Activator Protein 1 Complex via Mitogen Activated Protein Kinase-Dependent Signaling Pathways. PLoS ONE 2014; 9(7) doi: 10.1371/journal.pone.0103828
|
| 476 |
Marco Di Pietropaolo, Chiara Briani, Giulia Francesca Federici, Massimo Marignani, Paola Begini, Gianfranco Delle Fave, Elsa Iannicelli. Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules. Clinical Imaging 2015; 39(3) doi: 10.1016/j.clinimag.2014.12.020
|
| 477 |
Magdalena Stepien, Talita Duarte‐Salles, Veronika Fedirko, Anne Floegel, Dinesh Kumar Barupal, Sabina Rinaldi, David Achaintre, Nada Assi, Anne Tjønneland, Kim Overvad, Nadia Bastide, Marie‐Christine Boutron‐Ruault, Gianluca Severi, Tilman Kühn, Rudolf Kaaks, Krasimira Aleksandrova, Heiner Boeing, Antonia Trichopoulou, Christina Bamia, Pagona Lagiou, Calogero Saieva, Claudia Agnoli, Salvatore Panico, Rosario Tumino, Alessio Naccarati, H. B(as). Bueno‐de‐Mesquita, Petra H. Peeters, Elisabete Weiderpass, J. Ramón Quirós, Antonio Agudo, María‐José Sánchez, Miren Dorronsoro, Diana Gavrila, Aurelio Barricarte, Bodil Ohlsson, Klas Sjöberg, Mårten Werner, Malin Sund, Nick Wareham, Kay‐Tee Khaw, Ruth C. Travis, Julie A. Schmidt, Marc Gunter, Amanda Cross, Paolo Vineis, Isabelle Romieu, Augustin Scalbert, Mazda Jenab. Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study. International Journal of Cancer 2016; 138(2) doi: 10.1002/ijc.29718
|
| 478 |
Fang Yuan, Lu-Shun Zhang, Hong-Yu Li, Miao Liao, MeiLi Lv, ChongJie Zhang. Influence of Angiotensin I-Converting Enzyme Gene Polymorphism on Hepatocellular Carcinoma Risk in China. DNA and Cell Biology 2013; 32(5) doi: 10.1089/dna.2012.1910
|
| 479 |
Ran Xu Zhu, Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen. Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. Gut and Liver 2016; 10(3) doi: 10.5009/gnl15257
|
| 480 |
Olivier Piot, Cyril Gobinet, Valérie Untereiner, Dimple Saikia, Ganesh D Sockalingum. Raman Spectroscopy Applied to Polymer Composites and Nanocomposites. 2026; doi: 10.1016/B978-0-443-15989-3.00011-0
|
| 481 |
|
| 482 |
Sudip Sanyal, Philipp Kron, Neil Wylie, Ernest Hildalgo, Giles J. Toogood, Peter Lodge. Outcomes of liver resection for hepatocellular carcinoma in octogenarians. HPB 2020; 22(9) doi: 10.1016/j.hpb.2020.01.006
|
| 483 |
Shaimaa Gamal Hassan Elofey, Nevine F. Shafik, Noha Hassan Radwan, Osman Mohammed Mansour, Rasha Mahmoud Allam, Samia Shouman, Iman Attia AbdelGawad. Relation between GSTP1 polymorphism and oxidative stress in patients with hepatocellular carcinoma. Journal of the Egyptian National Cancer Institute 2020; 32(1) doi: 10.1186/s43046-020-00049-x
|
| 484 |
Lisha Mou, Kang Li, Chenyang Xu, Irene Xu, Yiyuan Yang, Zuhui Pu. Construction of endothelial cell‐related and autophagy‐related prognostic models for hepatocellular carcinoma based on single‐cell data. Journal of Gastroenterology and Hepatology 2023; 38(5) doi: 10.1111/jgh.16172
|
| 485 |
Liang Shi, Yili Feng, Hui Lin, Rui Ma, Xiujun Cai. Role of estrogen in hepatocellular carcinoma: is inflammation the key?. Journal of Translational Medicine 2014; 12(1) doi: 10.1186/1479-5876-12-93
|
| 486 |
Nastaran Hajizadeh, Ahmad Reza Baghestani, Mohamad Amin Pourhoseingholi, Sara Ashtari, Zeinab Fazeli, Mohsen Vahedi, Mohammad Reza Zali. Trend of hepatocellular carcinoma incidence after Bayesian correction for misclassified data in Iranian provinces. World Journal of Hepatology 2017; 9(15): 704-710 doi: 10.4254/wjh.v9.i15.704
|
| 487 |
Laura Ladrón de Guevara,, Paulo Rojas-Macuil, Xochiquetzal Sánchez-Chávez, Alejandro Rossano-García,, Ma. Teresa Gorraez-de-la-Mora,, Guadalupe Cervantes-Sánchez,, Julita Orozco-Vázquez, Mario Lemus-Velázquez,, Leticia Rosas-Zúñiga,, Aura Erazo-Valle,, Mauricio Di-Silvio. Hepatocellular carcinoma: Epidemiological profile from a cohort of federal employees in Mexico. Annals of Hepatology 2009; 8(3) doi: 10.1016/S1665-2681(19)31768-5
|
| 488 |
Junfa Yang, Changyao Li, Lei Zhang, Xiao Wang. Extracellular Vesicles as Carriers of Non-coding RNAs in Liver Diseases. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00415
|
| 489 |
Xin you Su, Jian Qiang Zhao, Nan Li, Mukesh Kumar, Ai mei Ou yang. Chemoprotective Effects of Resveratrol Against Diethylnitrosamine Induced Hepatocellular Carcinoma in Wistar Rats. International Journal of Pharmacology 2019; 15(5) doi: 10.3923/ijp.2019.549.559
|
| 490 |
Diego Elias Montoya-Durango, Leila Gobejishvili. Long noncoding RNA H19 in liver development and disease. Cellular Signalling 2026; 142 doi: 10.1016/j.cellsig.2026.112413
|
| 491 |
Hang Yuan, Jiaxi Mao, Cong Liu, Hong Fu, Wenyuan Guo, Guoshan Ding. Risk of adverse events in advanced hepatocellular carcinoma with immune checkpoint therapy: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2020; 44(6) doi: 10.1016/j.clinre.2020.02.012
|
| 492 |
Michele Di Martino, Gianmaria De Filippis, Adriano De Santis, Daniel Geiger, Maurizio Del Monte, Concetta Valentina Lombardo, Massimo Rossi, Stefano Ginanni Corradini, Gianluca Mennini, Carlo Catalano. Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging. European Radiology 2013; 23(4) doi: 10.1007/s00330-012-2691-z
|
| 493 |
Jui-Hsiang Lin, An-Shun Tai, Sheng-Hsuan Lin. Population attributable fraction based on marginal sufficient component cause model for mediation settings. Annals of Epidemiology 2022; 75 doi: 10.1016/j.annepidem.2022.08.050
|
| 494 |
Yen-Ju Chen, Chih-Jung Shen, Shao-Hua Yu, Cheng-Li Lin, Hong-Mo Shih. Increased risk of hepatocellular carcinoma in patients with traumatic liver injury. Medicine 2022; 101(6) doi: 10.1097/MD.0000000000028837
|
| 495 |
Ahmed Tayel, Khaled H. Abd El Galil, Mohamed A. Ebrahim, Ahmed S. Ibrahim, Amal M. El-Gayar, Mohammed M.H. Al-Gayyar. Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme. European Journal of Pharmacology 2014; 728 doi: 10.1016/j.ejphar.2014.02.001
|
| 496 |
Hans‐Christian Pommergaard. Prognostic biomarkers in and selection of surgical patients with hepatocellular carcinoma. APMIS 2023; 131(S146) doi: 10.1111/apm.13309
|
| 497 |
Silvia Gangemi, Eliza Gofita, Chiara Costa, Michele Teodoro, Giusi Briguglio, Dragana Nikitovic, George Tzanakakis, Aristides M. Tsatsakis, Martin F. Wilks, Demetrios A. Spandidos, Concettina Fenga. Occupational and environmental exposure to pesticides and cytokine pathways in chronic diseases (Review). International Journal of Molecular Medicine 2016; 38(4) doi: 10.3892/ijmm.2016.2728
|
| 498 |
Jeong Min Lee, Dong Ho Lee, Jeong-Hee Yoon. Multislice-CT of the Abdomen. Medical Radiology 2012; doi: 10.1007/174_2012_538
|
| 499 |
CHENG-LIANG ZHU, DUO-ZHI CHENG, FANG LIU, XIAO-HONG YAN, KAI-LANG WU, FU-BING WANG, XING-HUI LIU. Hepatitis B virus upregulates the expression of kinesin family member 4A. Molecular Medicine Reports 2015; 12(3) doi: 10.3892/mmr.2015.3792
|
| 500 |
Shaobo Zhang, Jian Qian, Qiang Cao, Pu Li, Meilin Wang, Jian Wang, Xiaobing Ju, Xiaoxin Meng, Qiang Lu, Pengfei Shao, Zhengdong Zhang, Chao Qin, Changjun Yin. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with renal cell cancer risk in a Chinese population. Mutagenesis 2014; 29(2) doi: 10.1093/mutage/geu001
|
| 501 |
M. A. D. Vente, J. F. W. Nijsen, R. de Roos, M. J. van Steenbergen, C. N. J. Kaaijk, M. J. J. Koster-Ammerlaan, P. F. A. de Leege, W. E. Hennink, A. D. van het Schip, G. C. Krijger. Neutron activation of holmium poly(L-lactic acid) microspheres for hepatic arterial radioembolization: a validation study. Biomedical Microdevices 2009; 11(4) doi: 10.1007/s10544-009-9291-y
|
| 502 |
Jin-yan Zhao, Zhi-hong Chen, Wei Lin, Xiao-yong Zhong, Xu-zheng Chen, Jun Peng, Zhen-feng Hong. Bear bile powder (熊胆粉) induces apoptosis of human hepatocellular carcinoma cells via mitochondrion-dependent pathway. Chinese Journal of Integrative Medicine 2014; 20(2) doi: 10.1007/s11655-013-1581-9
|
| 503 |
Teddy Saliba, Stephan Dorkhom, Eileen M. OʼReilly, Emmy Ludwig, Bolorsukh Gansukh, Ghassan K. Abou-Alfa. Hepatocellular carcinoma in two patients with cardiac cirrhosis. European Journal of Gastroenterology & Hepatology 2010; 22(7) doi: 10.1097/MEG.0b013e32832e2bec
|
| 504 |
LI ZHANG, CUIJU WANG, SHUFENG LIU, YUFEI ZHAO, CHAO LIU, ZHANJUN GUO. Prognostic significance of Dicer expression in hepatocellular carcinoma. Oncology Letters 2016; 11(6) doi: 10.3892/ol.2016.4547
|
| 505 |
Jaitip Tipanee, Mario Di Matteo, Warut Tulalamba, Ermira Samara-Kuko, Jiri Keirsse, Jo A. Van Ginderachter, Marinee Khim Chuah, Thierry VandenDriessche. Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons. Molecular Therapy - Nucleic Acids 2020; 19 doi: 10.1016/j.omtn.2020.01.015
|
| 506 |
Talita Duarte‐Salles, Veronika Fedirko, Magdalena Stepien, Krasimira Aleksandrova, Christina Bamia, Pagona Lagiou, Anne Sofie Dam Laursen, Louise Hansen, Kim Overvad, Anne Tjønneland, Marie‐Christine Boutron‐Ruault, Guy Fagherazzi, Mathilde His, Heiner Boeing, Verena Katzke, Tilman Kühn, Antonia Trichopoulou, Elissavet Valanou, Maria Kritikou, Giovanna Masala, Salvatore Panico, Sabina Sieri, Fulvio Ricceri, Rosario Tumino, H. B(as) Bueno‐de‐Mesquita, Petra H. Peeters, Anette Hjartåker, Guri Skeie, Elisabete Weiderpass, Eva Ardanaz, Catalina Bonet, Maria‐Dolores Chirlaque, Miren Dorronsoro, J. Ramón Quirós, Ingegerd Johansson, Bodil Ohlsson, Klas Sjöberg, Maria Wennberg, Kay‐Tee Khaw, Ruth C. Travis, Nick Wareham, Pietro Ferrari, Heinz Freisling, Isabelle Romieu, Amanda J. Cross, Marc Gunter, Yunxia Lu, Mazda Jenab. Dietary fat, fat subtypes and hepatocellular carcinoma in a large European cohort. International Journal of Cancer 2015; 137(11) doi: 10.1002/ijc.29643
|
| 507 |
Flávia Miryan Martins Almeida de Mello, Aline Satie Oba Kuniyoshi, André Fanhani Lopes, Michele Soares Gomes-Gouvêa, Dennis Armando Bertolini. Hepatitis B virus genotypes and mutations in the basal core promoter and pre-core/core in chronically infected patients in southern Brazil: a cross-sectional study of HBV genotypes and mutations in chronic carriers. Revista da Sociedade Brasileira de Medicina Tropical 2014; 47(6) doi: 10.1590/0037-8682-0158-2014
|
| 508 |
Ina Schönfeld, Klaus Kraywinkel. Epidemiologie des hepatozellulären Karzinoms in Deutschland. Der Onkologe 2018; 24(9) doi: 10.1007/s00761-018-0438-4
|
| 509 |
Yunlong Zhao, Letian Xie, Binwei Liu, Yulin Deng, Pengfei Li, Yuqing Dai, Jiao Liu, Chun Yi. Novel insight into the role of Src family kinases in hepatocellular carcinoma and therapeutic potential. Biochemical and Biophysical Research Communications 2025; 772 doi: 10.1016/j.bbrc.2025.151970
|
| 510 |
Pierre-Benoit Ancey, Barbara Testoni, Marion Gruffaz, Marie-Pierre Cros, Geoffroy Durand, Florence Le Calvez-Kelm, David Durantel, Zdenko Herceg, Hector Hernandez-Vargas. Genomic responses to hepatitis B virus (HBV) infection in primary human hepatocytes. Oncotarget 2015; 6(42) doi: 10.18632/oncotarget.6270
|
| 511 |
Maria-Aggeliki Kalogeridi, Anna Zygogianni, George Kyrgias, John Kouvaris, Sofia Chatziioannou, Nikolaos Kelekis, Vassilis Kouloulias. Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review. World Journal of Hepatology 2015; 7(1): 101-112 doi: 10.4254/wjh.v7.i1.101
|
| 512 |
Concetta Panebianco, Adele Potenza, Angelo Andriulli, Valerio Pazienza. Exploring the microbiota to better understand gastrointestinal cancers physiology. Clinical Chemistry and Laboratory Medicine (CCLM) 2018; 56(9) doi: 10.1515/cclm-2017-1163
|
| 513 |
Jiumao Lin, Aling Shen, Hongwei Chen, Jun Liao, Teng Xu, Liya Liu, Jing Lin, Jun Peng. Nitidine chloride inhibits hepatic cancer growth via modulation of multiple signaling pathways. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-729
|
| 514 |
Mark Benedict, Xuchen Zhang. Non-alcoholic fatty liver disease: An expanded review. World Journal of Hepatology 2017; 9(16): 715-732 doi: 10.4254/wjh.v9.i16.715
|
| 515 |
Elaine Holmes, Anisha Wijeyesekera, Simon D. Taylor-Robinson, Jeremy K. Nicholson. The promise of metabolic phenotyping in gastroenterology and hepatology. Nature Reviews Gastroenterology & Hepatology 2015; 12(8) doi: 10.1038/nrgastro.2015.114
|
| 516 |
Ce Chao, Renzhe Tang, Jiamin Zhao, Dongmei Di, Yongxiang Qian, Bin Wang. Oncogenic roles and related mechanisms of the long non-coding RNA MINCR in human cancers. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1087337
|
| 517 |
Michele Molinari, Christof Kaltenmeier, Patrick-Bou Samra, Hao Liu, Charles Wessel, Mary Lou Klem, Stalin Dharmayan, Bishoy Emmanuel, Hasan Al Harakeh, Samer Tohme, David Geller, Amit Tevar, Christopher B. Hughes, Abhinav Humar, Ramon Bataller, Jaideep Behari. Hepatic Resection for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Annals of Surgery Open 2021; 2(2) doi: 10.1097/AS9.0000000000000065
|
| 518 |
Massimiliano Berretta, Michele Caraglia, Ferdinando Martellotta, Silvia Zappavigna, Angela Lombardi, Carla Fierro, Luigi Atripaldi, Tommaso Muto, Daniela Valente, Paolo De Paoli, Umberto Tirelli, Raffaele Di Francia. Drug–Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00071
|
| 519 |
Wei Liu, Fang Tian, Liping Dai, Yurong Chai. Cytochrome P450 2E1 gene polymorphism and alcohol drinking on the risk of hepatocellular carcinoma: a meta-analysis. Molecular Biology Reports 2014; 41(11) doi: 10.1007/s11033-014-3655-y
|
| 520 |
Norhanan Hamzah, Nur Karyatee Kassim, Julia Omar, Mohd Shafie Abdullah, Yeong Yeh Lee. Levels of PIVKA-II and alpha-fetoprotein in unresectable hepatocellular carcinoma compared to healthy controls and predictive values of both markers with radiological responses after loco-regional interventions. PeerJ 2023; 11 doi: 10.7717/peerj.15988
|
| 521 |
Nada Assi, Anne Fages, Paolo Vineis, Marc Chadeau-Hyam, Magdalena Stepien, Talita Duarte-Salles, Graham Byrnes, Houda Boumaza, Sven Knüppel, Tilman Kühn, Domenico Palli, Christina Bamia, Hendriek Boshuizen, Catalina Bonet, Kim Overvad, Mattias Johansson, Ruth Travis, Marc J. Gunter, Eiliv Lund, Laure Dossus, Bénédicte Elena-Herrmann, Elio Riboli, Mazda Jenab, Vivian Viallon, Pietro Ferrari. A statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study. Mutagenesis 2015; doi: 10.1093/mutage/gev045
|
| 522 |
Robin K. Kelley, Alan P. Venook. Sorafenib in Hepatocellular Carcinoma: Separating the Hype From the Hope. Journal of Clinical Oncology 2008; 26(36) doi: 10.1200/JCO.2008.19.7996
|
| 523 |
Jan Vargas, Mathew Gowans, William A. Vandergrift, Pierre Giglio, Jason Hope. Metastatic Hepatocellular Carcinoma With Associated Spinal Cord Compression. The American Journal of the Medical Sciences 2011; 341(2) doi: 10.1097/MAJ.0b013e3181f7a49a
|
| 524 |
Xu Chao, Xuesong Feng, Hailong Shi, Yuewen Wang, Lanlan Wang, Haiyu Shen, Qing Zha, Yanni Chen, Chao Jiang.
MIR17HG polymorphism (rs7318578) is associated with liver cancer risk in the Chinese Han population. Bioscience Reports 2020; 40(8) doi: 10.1042/BSR20193312
|
| 525 |
M Arafa, T Besheer, AM El-Eraky, SM Abo El-khair, AZ Elsamanoudy. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients. British Journal of Biomedical Science 2019; 76(2) doi: 10.1080/09674845.2019.1594487
|
| 526 |
Rajesh Melaram. Environmental Risk Factors Implicated in Liver Disease: A Mini-Review. Frontiers in Public Health 2021; 9 doi: 10.3389/fpubh.2021.683719
|
| 527 |
Ping Wang, Donghong Kang, Wei Cao, Yan Wang, Zhiwen Liu. Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysis. Diabetes/Metabolism Research and Reviews 2012; 28(2) doi: 10.1002/dmrr.1291
|
| 528 |
|
| 529 |
Ya-Wen Cheng, Kai-Wei Chen, Han-Chun Kuo, Ching-Hua Kuo, Wei-Hsiang Lin, Pei-Jer Chen, Shiou-Hwei Yeh. Specific diacylglycerols generated by hepatic lipogenesis stimulate the oncogenic androgen receptor activity in male hepatocytes. International Journal of Obesity 2019; 43(12) doi: 10.1038/s41366-019-0431-z
|
| 530 |
Jui-Kun Chiang, Lin Chih-Wen, Yee-Hsin Kao. Effect of ultrasonography surveillance in patients with liver cancer: a population-based longitudinal study. BMJ Open 2017; 7(6) doi: 10.1136/bmjopen-2017-015936
|
| 531 |
Mrigaya Mehra, Ranjit Chauhan. Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma. Biomarkers in Cancer 2017; 9 doi: 10.1177/1179299X17737301
|
| 532 |
E. Okeke, P. Mark Davwar, B. Mullen, M. Duguru, O. Agbaji, A. Sagay, R. Murphy, C. Hawkins. The impact of HIV on hepatocellular cancer survival in Nigeria. Tropical Medicine & International Health 2021; 26(3) doi: 10.1111/tmi.13532
|
| 533 |
Jelena Jadzic, Danijela Djonic. Hepatocellular carcinoma and musculoskeletal system: A narrative literature review. World Journal of Gastroenterology 2024; 30(15): 2109-2117 doi: 10.3748/wjg.v30.i15.2109
|
| 534 |
Lorenzo Monfardini, Franco Orsi, Silvio Monfardini. Interventional Oncology for Older Patients in Liver and Kidney Malignancies. Aging Health 2012; 8(3) doi: 10.2217/ahe.12.18
|
| 535 |
Magdalena Stepien, Talita Duarte-Salles, Veronika Fedirko, Antonia Trichopoulou, Pagona Lagiou, Christina Bamia, Kim Overvad, Anne Tjønneland, Louise Hansen, Marie-Christine Boutron-Ruault, Guy Fagherazzi, Gianluca Severi, Tilman Kühn, Rudolf Kaaks, Krasimira Aleksandrova, Heiner Boeing, Eleni Klinaki, Domenico Palli, Sara Grioni, Salvatore Panico, Rosario Tumino, Alessio Naccarati, H. Bas Bueno-de-Mesquita, Petra H. Peeters, Guri Skeie, Elisabete Weiderpass, Christine L. Parr, José Ramón Quirós, Genevieve Buckland, Esther Molina-Montes, Pilar Amiano, Maria-Dolores Chirlaque, Eva Ardanaz, Emily Sonestedt, Ulrika Ericson, Maria Wennberg, Lena Maria Nilsson, Kay-Tee Khaw, Nick Wareham, Kathryn E. Bradbury, Heather A. Ward, Isabelle Romieu, Mazda Jenab. Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort. European Journal of Nutrition 2016; 55(1) doi: 10.1007/s00394-014-0818-5
|